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ABSTRACT 
The development of the sympathoadrenal (SA) lineage has been studied as a model 
system in which to investigate the mechanisms that control the timing of environmental 
influences on cell fate. Glucocorticoids (GC) playa key role in the fate of the SA 
progenitor, causing it to differentiate to an adrenal chromaffin cell, rather than to a 
sympathetic neuron. Previously, it has been shown that GC exert both positive and 
negative effects on developing chromaffin cells: they promote cell survival and the 
expression of an adrenergic phenotype, and inhibit the expression of neuronal properties. 
However, the time at which GC first influence cell fate, and the mechanism(s) which 
underlie its effect(s), have remained matters of controversy. In this thesis, it is shown that 
the positive and negative effects of GC on SA progenitors during development are 
temporally separated and pharmacologically distinct. Most SA progenitors are competent 
to respond to GC by inhibition of process outgrowth two days before they are competent 
to respond by induction of PNMT, a chromaffm-specific marker. Competence to express 
PNMT appears to be acquired according to a cell-autonomous "clock". The early 
inhibition of neuronal differentiation may be a prerequisite to subsequent PNMT 
expression, since sympathetic neuroblasts rapidly lose the capacity to express PNMT. 
The two effects of GC are both mediated via the type-II glucocorticoid receptor (GCR). 
However, lower concentrations of GC are required to inhibit neuronal differentiation than 
to promote the expression of PNMT, and the two effects show differential responsiveness 
towards the receptor-specific antagonist RU38486. That the two effects of GC in this 
system are pharmacologically separable suggests that they may be mediated via different 
interactions of the GCR with endogenous cellular transcription machinery. Such 
differential interactions may explain how the two effects of GC in this system are 
temporally separated. Taken together, the results presented here provide precedent for an 
inductive developmental event in which the timing of the effects of an instructive signal on 
a bipotential progenitor are controlled neither by the schedule of appearance of the signal, 
nor of its receptor, but rather by cell-intrinsic, developmental changes in the response 
properties of the cell. 
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The development of an embryo proceeds as a carefully timed 
sequence of events that leads to the diversification of particular cell types 
and their organization into discrete macroscopic structures. In molecular 
terms, this sequence of events is understood to consist primarily of the 
ordered control of gene expression by both environmental and genetic cues. 
Moreover, the induction or repression of one set of genes is often a 
prerequisite to the subsequent induction or repression of a second set of 
genes, and so on. Thus, particular cell fates are essentially reflections of 
particular developmental histories that have progressed according to 
particular schedules. Despite the importance of these schedules of 
differentiation, however, the mechanisms that control their timing are not 
well understood. 
One of the few systems in which the issue of timing has been carefully 
studied is the schedule of glial cell differentiation in the rat optic nerve 
(Raff, 1989; Lillien and Raff, 1990). In this system, 02A bipotential progenitor 
cells give rise first to oligodendrocytes at around the time of birth, and then 
subsequently also differentiate to type 2 astrocytes approximately two weeks 
later. The timing of these events appears to be controlled in two different 
ways by soluble factors that are produced by a third cell type, the type-1 
astrocytes (Hughes and Raff, 1987; Richardson et aI., 1988). One of these 
factors, PDGF, serves as a mitogen for 02A progenitors that is permissive for 
the running of a cell-autonomous clock that counts a certain number of cell 
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divisions (Noble et aI., 1988; Raff et aI., 1988). Once this number has been 
reached, cell division stops and the progenitors differentiate to 
oligodendrocytes. A second environmental signal, CNTF, acts differently: it 
appears to be instructive, rather than permissive, for the differentiation of 
the 02A progenitor into type-2 astrocytes (Hughes et aI., 1988; Lillien et aI., 
1988). The time at which type-2 astrocytes differentiate appears to be directly 
determined by the time at which CNTF begins to be released by type-1 
astrocytes (Lillien et aI., 1988). Two different mechanisms for the temporal 
control of differentiation thus emerge from these studies: one involves the 
continued presence of an environmental signal that allows a cell-intrinsic 
program to run, while the other involves an instructive environmental 
signal whose delayed time of appearance controls the timing of an inductive 
event. 
Studies of the 02A progenitor have yielded considerable insight into 
the temporal control of differen tiation within glial cell lineages. Little is 
known, however, about the events that control the timing of 
developmental decisions within neuronal cell lineages. One of the few 
neuronal cell lineages whose development has been studied in considerable 
detail is the neural crest-derived sympathoadrenal (SA) lineage (Landis and 
Patterson, 1981; Patterson, 1990). While the mechanisms that underly the 
schedule of sympathoadrenal differentiation have not been previously well 
established, environmental factors which influence cell fate within this 
lineage have been identified and characterized. 
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The Sympathoadrenal Lineage 
Transplantation experiments using the chick-quail chimera system 
have established that cells in the SA lineage arise from the trunk region of 
the spinal neural crest between the levels of somites 18 and 24 (LeDouarin, 
1980). These cells, like other crest derivatives, appear to be initially 
multipotent (Baroffio et aI., 1988; Bronner-Fraser and Fraser, 1989), and then 
subsequently become progressively restricted in their choice of cell fate, 
presumably by environmental factors that they encounter during the course 
of their migration. Ultimately, cells in the SA lineage give rise to the major 
catecholaminergic cell types: adrenal medullary chromaffin cells, 
sympathetic neurons, and small intensely fluorescent (SIF) cells (Landis and 
Patterson, 1981; Patterson, 1990). Chromaffin cells are relatively small, 
contain large amine-storing vesicles, display a characteristically round 
morphology, ,and synthesize norepinephrine and epinephrine. Sympathetic 
neurons, by contrast, have large cell bodies, contain much smaller vesicles, 
extend long processes, and synthesize norepinephrine, but not epinephrine 
(see e.g., Doupe et aI., 1985a). The lack of epinephrine synthesis in 
sympathetic neurons is a consequence of their failure to express the enzyme 
phenylethanolamine N-methyltransferase (PNMT), which catalyzes the 
conversion of norepinephrine into epinephrine. SIF cells have properties 
that are intermediate between sympathetic neurons and chromaffin cells 
(Eranko, 1975), and can display either neuronal or chromaffin properties, 
depending on their hormonal milieu (Doupe et al., 1985b). 
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What are the environmental signals that influence the differentiation 
of cells in the SA lineage? Early studies both in vivo and in vitro clearly 
established nerve growth factor (NGF) as a survival factor for sympathetic 
neurons (Levi-Montalcini and Angeletti, 1963; Levi-Montalcini and 
Angeletti, 1968). Conversely, Wurtman and Axelrod showed that 
glucocorticoids (GC) produced by the adrenal cortex are required for the 
maintenance of epinephrine synthesis in chromaffin cells (Wurtman and 
Axelrod, 1966). That NGF and GC are critical environmental determinants 
of cell fate in the SA lineage was initially suggested by experiments in vitro 
that revealed the plasticity of chromaffin cells. Unsicker and coworkers 
demonstrated that NGF could induce mature chromaffin cells in dissociated 
cultures to transdifferentiate to cells resembling sympathetic neurons. 
Moreover, this effect of NGF on neuronal differentiation could be blocked by 
GC (Unsicker et aI., 1978). Doupe, Landis and Patterson extended these 
studies in long-term postnatal chromaffin cell cultures, and clearly 
established GC as a survival factor for these cells. They showed, moreover, 
that long-term exposure to NGF converted chromaffin cells into cells that 
were indistinguishable from sympathetic neurons (Doupe et aI., 1985a). 
More recent studies of postnatal chromaffin cells indicate that acidic and 
basic fibroblast growth factor (aFGF, bFGF), as well as NGF, can initiate this 
process of transdifferentiation (Claude et aI., 1988; Stemple et aI., 1988). 
Studies on committed embryonic SA progenitor cells in vitro have 
strongly supported the suggestion from studies of postnatal cells, that NGF 
and GC respectively influence the initial development of sympathetic 
neurons and chromaffin cells. Using the monoclonal antibody B2 as a tag for 
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fluorescence-activated cell-sorting (FACS), Anderson and Axel were able to 
isolate a purified population of bipotential progenitor cells (SA progenitors) 
from embryonic day 14.5 (E14.5) rat adrenal glands that differentiated to 
sympathetic neurons in the presence of NGF, and to PNMT+ chromaffin 
cells in the presence of GC (Anderson and Axel, 1986). Carnahan and 
Patterson used the monoclonal antibody SA-l to isolate bipotential 
progenitor cells by FACS from E13.5 rat superior cervical ganglia (SCG) that 
behaved in a similar manner in response to these environmental factors 
(Carnahan and Patterson, 1991), confirming earlier studies of neonatal SCG. 
Studies of the effects of bFGF, NGF and GC on an immortalized cell line 
derived from E14.5 SA progenitors have provided further evidence for a 
decisive role for these factors in the determination of cell fate within the SA 
lineage (Birren and Anderson, 1990). 
The foregoing in vitro data indicate that neurotrophic factors and GC 
have opposite effects on SA progenitor cells. Moreover, they suggest that 
each of these factors have both positive and negative effects on these cells: 
neurotrophic factors promote the expression of neuronal properties and 
repress the expression of chromaffin properties; conversely, GC promote the 
expression of chromaffin properties and inhibit the expression of neuronal 
properties. These complementary influences are consistent with the pattern 
of antigenic marker expression and repression by SA progenitors in vivo. At 
El1.5, SA progenitors initially coexpress neuronal and chromaffin markers 
(Cochard and Paulin, 1984; Anderson and Axel, 1985; Anderson et aI., 1991) 
(Appendix III, this volume). Progenitors that remain in the ganglia continue 
to express neuronal markers, but extinguish the expression of chromaffin 
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markers. Cells that migrate to the adrenal anlage display the converse 
behavior, extinguishing the expression of neuronal markers and continuing 
to express chromaffin markers (Anderson and Axel, 1985; Anderson et aI., 
1991) (Appendix III, this volume). Taken together, the in vitro and in vivo 
data suggest that both sympathetic neurons and chromaffin cells derive 
from a common embryonic progenitor cell whose choice of cell fate is 
controlled by the environmental factors that it encounters as it migrates. 
Those cells which arrest their migration in sympathetic ganglia encounter 
neurotrophic factors that promote neuronal differentiation. By contrast, cells 
that continue their migration to the adrenal gland encounter high levels of 
GC produced by the adrenal cortex, that act to promote chromaffin 
differentiation. It is interesting that although the adrenal cortex and medulla 
perform essentially independent physiological functions, GC produced by 
the cortex also appear to be necessary for both the maintenance of the 
medullary (chromaffin) phenotype (see above), and for the proper 
development of this phenotype. 
While it is clear that . particular environmental signals influence the 
fate of developing SA progenitor cells, the mechanisms that control the 
timing of their effects have not been well understood. The experiments 
presented in this thesis focus in particular on the temporal control by GC of 
chromaffin cell differentiation. Previous studies that have addressed this 
issue have assumed that the schedule of differentiation is determined either 
by the time of appearance of GC, or of its receptor. The results of the 
experiments in this thesis suggest that neither of these mechanisms is 
correct. This conclusion appears to fit well with recent studies of gene 
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regulation by steroid hormones which indicate that the presence of liganded 
receptor per se is not necessarily sufficient for activation or repression of 
transcription. Therefore, before proceeding further with a discussion of the 
issue of timing as it relates to the development of the adrenal gland, 
contemporary views on the control of gene expression by steroid hormones 
will be discussed. Several comprehensive reviews of this subject have been 
published in recent years (Evans, 1988; Evans and Arriza, 1989; Beato, 1989; 
Beato et al., 1989; Gustafsson et ai., 1990; Pratt, 1990). As a prelude to this 
discussion, an overview of glucocorticoids and their receptors in the 
nervous system is presented. 
Mechanisms of glucocorticoid honnone action 
Glucocorticoid receptors in the nervous system 
At least two types of glucocorticoid receptors (GCRs) have been 
identified and characterized in the nervous system, and these correspond in 
structure to the two primary types of GCRs described in other systems. The 
type-I GCR, the so-called "mineralocorticoid" receptor (MR), has an equally 
high affinity for both corticoisterone and the principal mineralocorticoid, 
aldosterone (Sheppard and Funder, 1987; Funder et al., 1988). By contrast, the 
type-II GCR (known as the "classical" GCR) has a much higher affinity than 
MR for synthetic glucocorticoids such as dexamethesone, but has a nearly 10-
fold lower affinity for corticosterone, and an even lower affinity still for 
aldosterone (see, eg., Reul and De Kloet, 1985). 
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In the brain, expression of the type-II GCR (hereafter referred to 
simply as "GCR") is much more widespread than is the expression of MR. 
Expression of MR in the brain is restricted mostly to the hippocampus and a 
few other telencephalic structures, but is generally absent from the 
diencephelon. GR, by contrast, is widely expressed in both di- and 
telencephalic regions (Fuxe et al., 1985; Van Eekelen et al., 1988; Van Eekelen 
et al., 1991). In situ hybridization studies have revealed quantitative 
differences in the levels of GR mRNA present in various brain regions (Van 
Eekelen, et al., 1991). Thus, whereas the highest levels of GR message are 
detected in the hippocampus and in the parvocellular layer of the 
hypothalamic paraventricular nucleus, levels are more modest in regions 
such as the thalamus and basal ganglia, confirming earlier 
immunohistochemical studies (Fuxe, et al., 1985). The observation of such 
heterogeneity in levels of GR message expression suggests that perhaps 
different levels of functional receptor may be required for different cellular 
effects. 
Despite the differences in localization of MR and GCR in the brain, a 
clear overlap in the expression of the two receptor types is evident in at least 
some sections of the hippocampus (notably the CAl and CA2 regions) (Van 
Eekelen, et al., 1988). The studies of Evans and coworkers suggest that this 
overlapping expression may be functionally significant, insofar as it could, 
in principle, constitute a 'biphasic response system' (Evans and Arriza, 1989). 
Since plasma GC concentrations can vary from the subnanomolar range at 
certain points during the circadian rhythm cycle up to levels exceeding 
100nM in response to stress, two receptor systems in the same cells may be 
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necessary to accomodate effective responses to such a wide range of steroid 
levels. 
Effects of GC on neural development 
In addition to their effects on sympathoadrenal development, GC also 
influence central nervous system ontogeny. Teratological studies have 
indicated that fetal exposure to high levels of GC profoundly affect brain 
development, causing the retardation of synpatogenesis, axonal outgrowth, 
cell division and myelinogenesis, among other abnormalities (see, eg., De 
Kloet et aI., 1988). Nevertheless, low levels of GC appear to be essential for 
normal development of the CNS. That GC may be involved in establishing 
neuronal topography in the brain is not altogether surprising, considering 
the well-documented effects of androgens and estrogens on the 
development of neuronal connections in sexually dimorphic regions of the 
brain of passerine songbirds (for review of the effects of steroids in the bird 
song system, see, eg., Konishi, 1989). However, despite numerous reports on 
the phenomenology of GC effects on cortical neurons, little is known about 
the cellular and molecular mechanisms of these effects. 
One aspect of GC regulation of brain development that has been 
studied in cellular and molecular detail is the control of myelination in the 
CNS. Type-II glucocorticoid receptors have been demonstrated to be 
localized at high levels within both oligodendrocytes and astrocytes 
(Vielkind et aI., 1990). In vivo studies have shown that adrenalectomy 
causes a profound decrease in CNS myelination (Preston and McMorris, 
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1984), and several glial enzymes and lipids important for myelination 
appear to be directly GC-inducible (Dawson and Kernes, 1979; Kumar et aI., 
1986; Warringa et aI., 1987; Kumar et aI., 1989). GC have also been shown to 
stimulate development of oligodendrocytes in primary glial cultures, and to 
act as a survival factor for these cells (Warringa, et aI., 1987). One of the most 
well-studied GC-inducible glial enzymes involved in myelination is 
glycerol-phosphate dehydrogenase (GPD). The continuous presence of GC 
appears to be required for both the induction and normal developmental 
increase in levels of this enzyme (Meyer, 1985). Recent studies using in vitro 
transcription assays indicate that the effect of GC on GPD expression occurs 
at the level of transcription (Kumar, et aI., 1989). It is interesting that 
whereas GPD is clearly regulated by GC in the CNS, its expression in other 
tissues such as liver and skeletal muscle appears to be GC-independent 
(Doupe and Patterson, 1982). 
Another well-studied case of GC effects on CNS development at the 
molecular level is the regulation by GC of glutamine synthetase (GS) 
expression in the retina. In the chick embryo, GS synthesis rises sharply 
around days E16-E17 of development, commensurate with a systemic rise in 
circulating GC levels (Moscona and Hubby, 1963; Moscona, 1972). Partial GS 
expression can be induced precociously by injections of GC as early as 
embryonic day 7-8, but not prior to this time (Paddington and Moscona, 1967; 
Soh and Sarkar, 1978; Moscona and Moscona, 1979; Patejunas and Young, 
1987), even though functional GCR is clearly present in the developing 
retina as early as E6 (Lippman et aI., 1974; Koehler and Moscona, 1975). It has 
therefore been suggested that other transcription factors may be required in 
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addition to the GCR in order to induce competence within the retina to 
express GS in response to GC (Patejunas and Young, 1987). Accordingly, the 
delay in GC-inducibility of GS expression may reflect a delay in the 
appearance of such an additional transcription factor. Interestingly, GS is GC-
inducible in muscle as well as the retina (Feng et al., 1990), but its expression 
in liver and hippocampus appears to be independent of GC (Patejunas and 
Young, 1987; Tombaugh and Sapolsky, 1990). Thus, GC-inducibility of GS, 
like GPD (see above), is tissue-specific, further underscoring the idea that 
steroid inducibility may involve synergistic interactions between GCR and 
cell-type-specific regulatory factors . An understanding of the possible nature 
of such interactions is perhaps best appreciated in the context of the 
molecular details of steroid receptor structure and target-gene promoters. 
Glucocorticoid receptor structure and function 
The glucocorticoid and mineralocorticoid receptors are members of a 
family of nuclear receptor proteins that also includes the progesterone, 
estrogen, androgen, thyroid and retinoic acid receptors, as well as several 
others for which a ligand has yet to be identified (for review, see Evans, 
1988). All of these molecules share a highly conserved cysteine-rich domain 
to which zinc atoms are liganded to form a structure for sequence-specific 
interactions with DNA (Klug and Rhodes, 1987; Evans and Hollenberg, 1988; 
Freedman et aI., 1988; Severne et aI., 1988). Similar to the structure first 
described for the Xenopus transcription factor TFIllA (Miller et al., 1985), this 
"zinc finger" region, located between the N-terminal and C-terminal 
domains of these molecules (see below), defines the DNA-binding domain 
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of what is known as the steroid hormone receptor superfamily. The 
sequence of this domain also shows robust homology to the DNA-binding 
domain of the viral oncogene v-erb-A (Weinberger et al., 1985). It also shows 
considerable homology to the knrl gene, whose product is closely related to 
that of the drosophila gap segmentation gene knirps, thus emphasizing the 
potentially important role that steroid receptors may play in governing 
developmental decisions (Oro et aI., 1989). 
Steroid receptors as a class also have two other major structural 
domains. The C-terminal region contains the hormone binding site. 
Deletion of this region results in the generation of receptors that can activate 
transcription in the absence of hormone, suggesting that in the absence of 
hormone this region inhibits the DNA-binding and activation functions 
that reside elsewhere in the receptors (Godowski et aI., 1987). The N-
terminal region contains a potent transcriptional activation function, called 
1:1 or TAP1, within an acidic region (Hollenberg and Evans, 1988). It shows 
substantial variability in length and sequence among different receptor types 
as well as among different isoforms of receptor for the same hormone, and 
has been implicated in the synergistic interaction with other transcription 
factors. The unique characteristics of this region may significantly influence 
the efficiency with which a receptor can activate target gene expression 
(Evans and Arriza, 1989). 
The DNA- and steroid-binding regions also contain activation 
functions, in addition to the one characterized in the N-terminal region 
(Hollenberg and Evans, 1988; Webster et aI., 1988; Schena et aI., 1989). In 
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addition, a nuclear localization signal lies in a region between the DNA- and 
steroid-binding regions (Picard et ai., 1990). Glucocorticoid receptors appear 
to be unique in that the steroid-binding domain of these receptors contain a 
second nuclear localization signal (Picard and Yamamoto, 1987), in addition 
to the one contained in the DNA-binding domain. This second signal is 
close to a site at which unliganded GC receptor can interact with the heat 
shock protein hsp90. Such receptor-hsp90 complexes have been shown to be 
important in mediating the ligand-induced transformation of steroid 
receptors to the DNA-binding state (Pratt et ai., 1988; Picard et ai., 1990b). 
Presumably, the binding of GC to its receptor induces a dissociation of, or 
conformational change in this complex that unmasks the nuclear 
localization signal and leads to translocation of the receptor across nuclear 
pores. More recent evidence indicates that hsp90 serves not only as a steric 
hindrance to the passage of unliganded receptor to the nucleus, but also 
actively facilitates the subsequent response to hormonal signal (Picard et ai., 
1990b). That the presence of a second nuclear localization signal is unique to 
GC receptors fits well with the observation that whereas progesterone and 
estrogen receptors are predominantly located in the nucleus both in the 
absence and presence of hormone, unliganded GC receptors are primarily 
located in the cytoplasm (Welshons et ai., 1984; Perrot-Applanat et ai., 1985; 
Picard and Yamamoto, 1987). 
DNA regulatory elements in glucocorticoid-responsive genes 
Postively regulated genes. Many genes that are positively regulated by 
steroids have been characterized. The positive action of glucocorticoids are 
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conferred by the binding of liganded receptor to specific glucocorticoid 
responsive elements (GREs) that can be located anywhere from tens to 
thousands of nucleotides upstream of transcription initiation sites. The 
consensus sequence for GREs consists of a palindromic 1S-mer (Beato, 1989) 
that binds receptor dimers (Chalepakis et aI., 1990). Progesterone, androgens 
and mineralocorticoid receptors can all activate transcription through 
binding to these cognate elements (Strahle et aI., 1987; Ham et aI., 1988). 
Recent studies suggest that the specificity of transcriptional control by these 
hormones is likely to be mediated within cells by their differential 
expression of particular hormone receptors, rather than by a differential 
dependence on additional transcription factors (Strahle et aI., 1989). 
Negatively regulated genes. Far fewer genes that are negatively 
regulated by steroids have been studied in detail. Of those that have been 
studied, virtually all involve transcriptional repression by Gc. In contrast to 
the positive GRE, a clear consensus sequence for negative regulation has 
been difficult to decipher. Several sequences to which GC receptor binds in 
promoters of negatively-regulated genes have been identified, and are 
referred to collectively as negative glucocorticoid responsive elements 
(nGREs). Some essential positions in positive GREs are also present in 
nGREs, but there appear to be particular differences as well. It is not yet clear 
whether in general, differences in nucleotide sequence in hormone 
responsive elements are sufficient to account for opposite effects on 
transcriptional control (Beato et aI., 1989), but this idea was originally 
proposed based on studies of the bovine prolactin gene (Sakai et ai., 1988). 
More recently, an nGRE has been characterized that overlaps a recognition 
element for the AP-1 class of transcription factors, and can confer either 
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positive or negative regulation, depending on which members of this class 
are also bound (see below) (Diamond et al., 1990). 
Coordinate regulation of gene expression by glucocorticoid receptors and 
other transcription factors 
Many studies have revealed that the regulation of transcription of 
steroid hormones can be modulated by other transcription factors, acting in 
concert with steroid receptors. These factors may act through binding to 
unique sites on DNA, or to steroid receptors themselves, or both. Such 
studies emphasize that the mere presence of liganded steroid receptor does 
not guarantee the efficient activation or repression of a steroid-regulatable 
gene; other factors may be necessary as well. 
The induction of aI-acidic glycoprotein (AGP) by GC, for example, can 
be inhibited by adding cycloheximide together with hormone (Klein et ai., 
1987). More recent studies of the AGP promoter reveal both functional GREs 
and sequences downstream of these receptor binding sites that are required 
for trans-activation of the AGP gene (Klein et ai., 1988). Footprinting analysis 
has shown that these downstream sequences bind a cycloheximide-sensitive 
factor. Thus, the activation of AGP transcription appears to involve the 
direct action on the AGP promoter of both the GC receptor and a different 
labile transcription factor. 
Studies of the MMTV promoter have revealed it to contain binding 
sites for at least three transcription factors: GC (or progesterone) receptor, 
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NF-l and OTF-l (oct-I). Mutations in the OTF-l binding sites completely 
abolish the stimulatory effect of progesterone receptor on transcription. 
Moreover, binding of this steroid receptor to the GRE, facilitates the binding 
of OTF-l to its cognate element. These results have suggested that the OTF-l 
transcription factor binds to a unique site but interacts directly with the GC 
receptor, bound to its unique site, to coordinately regulate transcription 
(Bruggemeier et aI., 1991). A similar case of protein-protein interactions is 
seen in the coordinate regulation of prolactin transcription in rat pituitary. 
Thus, estrogen receptor can mediate a large increase in prolactin expression 
by binding to an estrogen response element and synergistically interacting 
with the pituitary-specific pit-1 transcription factor bound to a different site 
(Simmons et aI., 1990). Interestingly, OTF-l and pit-l are both members of 
the POU-domain family of transcriptional activators (Ingraham et aI., 1990). 
Such synergistic protein-protein interactions between steroid receptors and 
POU domain factors may reflect a common mode of coordinate regulation of 
gene expression. 
Recent studies have characterized a system in which different protein-
protein interactions can result in either positive or negative transcriptional 
regulation by GC, at a single nGRE (Diamond, et aI., 1990). Thus, an nGRE 
located within the rat proliferin promoter contains overlapping binding 
sites for both the GC receptor and members of the AP-l class of transcription 
factors (see above). When jun-jun homodimers are bound to this nGRE, 
proliferin is only basally induced; liganded GC receptor confers a robust 
upregulation of transcription. By contrast, jun-fos heterodimers bind this 
nGRE in the absence of GC receptor to activate transcription, which can then 
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be repressed by the additional binding of liganded GC receptor. Regulation of 
transcription at this nGRE can thus involve either synergistic or antagonist 
protein-protein interactions between the two classes of transcription factors. 
The examples offered here clearly indicate that the mere presence of 
hormone-bound receptor is not necessarily sufficient to regulate 
transcription of steroid-responsive genes; other factor(s) are likely to be 
required as well. Moreover, the regulation of different genes may require 
different classes of transcription factors. With this idea in mind, the 
concluding sections of this introduction present an overview of previous 
attempts to explain the timing of a maturation event in the development of 
adrenal chromaffin cells -- the onset of PNMT expression -- which occurs in 
vivo with striking temporal specificity. This discussion is introduced within 
the context of PNMT expression in general, and the structure of the PNMT 
gene in particular. 
Expression of PNMT in the nervous system 
In addition to its expression in the adrenal medulla, PNMT is also 
expressed in several regions of the central nervous system. For example, 
adrenergic neurons in the C1 regions of the brainstem send descending 
axons into the spinal cord that appear to synapse directly on adrenal 
preganglionic neurons (Bernstein-Goral and Bohn, 1988; Bernstein-Goral 
and Bohn, 1989). PNMT has also been detected in neurons that project to the 
paraventricular nucleus of the hypothalamus (Liposits et aI., 1990). BotJ;t 
immunohistochemical and lesion studies indicate that PNMT is expressed 
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as well in at least some cell bodies of the hypothalamus itself (Ruggiero et 
al., 1985; Masana and Mefford, 1989). Additionally, PNMT has been detected 
in small amacrine neurons within the retina (see (Baetge et aI., 1988) for 
references). 
In contrast to the sympathetic nervous system, where PNMT is clearly 
GC-inducible, at least one study has suggested that expression of the 
adrenergic phenotype within the central nervous system is not under GC 
control (Bohn et aI., 1987). In explants of embryonic rat brainstem isolated at 
E13, natural GC such as corticosterone had no effect on PNMT activity at any 
time in culture; the enzyme appeared even in the absence of steroid. 
Moreover, GC antagonists were unable to prevent the developmental 
increase in PNMT activity within this tissue. Oexamethesone had a slight 
inductive effect on enzyme levels after three weeks in culture, but this effect 
could not be blocked by GCR antagonists. Thus, the expression of PNMT, 
like the expression of GS and GPO (see above), may be differentially 
regulated in a tissue-specific manner. 
The PNMT gene 
In recent years, the PNMT gene has been cloned from rat, bovine and 
human genomic libraries (Batter et al., 1988; Sasaoka et aI., 1989; Ross et aI., 
1990). All three genes are very similar to each other: their coding regions all 
span approximately two kilobases, consist of three exons, and contain 
several GREs as well as several putative binding sites for the transcription 
factor Spl, to which the GREs are generally adjacent. Regulatory elements 
2) 
for tissue-specific expression of PNMT appear to be present within a two-
kilobase 5' -flanking region of the PNMT gene, since in transgenic mice, a 
chimeric transgene made up of this flanking sequence fused to the SV40 
early region initiated tumors specifically within the adrenal medulla and 
retina (Baetge, et aI., 1988). Transgenes were not expressed, however, in 
other known PNMT-immunoreactive brain regions such as the brainstem, 
consistent with the idea that normal PNMT expression in various tissues 
may be differentially regulated. 
Only one recent study has investigated the transcriptional regulation 
of PNMT. Goodman and coworkers found that PNMT-I3-galactosidase 
constructs containing a functional GRE are expressed when transfected into 
primary adult chromaffin celis, but not in PC12 cells (Ross, et aI., 1990). Since 
both of these cell types express functional GCR, but only chromaffin cells 
express PNMT, these data support the idea that additional regulatory factors, 
differentially expressed in chromaffin cells and PCl2 cells, may be necessary, 
in addition to functional GCR, in order to activate transcription of the 
PNMT gene. 
Temporal control of chromaffin cell development 
The developmental onset of epinephrine synthesis 
In the rat, migrating SA progenitor cells invade the adrenal anlage 
between embryonic days 12 and 15 of development (Lempinen, 1964; Bohn 
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et ai., 1981). There they encounter presumptive cortical cells, which are 
already present in the area by this time. After a delay of several days, the SA 
progenitors begin to express PNMT at around E17, and the levels of enzyme 
increase dramatically thereafter (Bohn et ai., 1981). 
Previous studies indicated that the timing of PNMT appearance (and 
the consequent synthesis of epinephrine) correlates with the time at which 
developing cortical cells are induced by ACTH to synthesize particularly 
high levels of GC (Cohen, 1976; Teitelman et ai., 1979). Earlier experiments 
demonstrated, moreover, that hypophysectomy prevents the normal 
developmental increase in epinephrine synthesis by chromaffin cells 
(Margolis etai., 1966). Taken together, these data suggested that the 
production of GC by cortical cells induces chromaffin cell progenitors to 
express PNMT, and that the delay in the appearance of this enzyme reflects a 
delay in the time at which the inducing signal, GC, first appears. Such a view 
is analagous to the role of CNTF in controlling the time of type-2 astrocyte 
differentiation in the 02A lineage (see above). 
Controversy over the role of GC as an inducing signal 
Early experiments attempted to verify GC as the inducing signal for 
chromaffin cell differentiation in vivo. It was reasoned that if GC do indeed 
control the timing of PNMT appearance, then it ought to be possible to effect 
an earlier induction of PNMT by experimentally elevating levels of GC 
several days before the normal time of appearance of this enzyme. Such 
manipulations of GC levels in vivo produced negative results (Bohn et ai., 
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1981). Moreover, whole adrenal glands in organ culture were shown to 
induce PNMT even in the absence of exogenously added steroid (Teitelman 
et aI., 1982). Although the concentrations of GC actually present in the 
vicinity of developing chromaffin cells could not be carefully controlled in 
either of these experiments, the authors of these studies concluded that GC 
are not required for the initial expression of epinephrine synthesis. This 
conclusion was bolstered by other studies indicating that low levels of 
PNMT are detectable in the developing adrenal 1 to 2 days before the surge 
in cortical steroidogenesis (Ehrlich et aI., 1989). All of these studies were 
interpreted within the framework that GC are not required for the initial 
expression of PNMT, but do mediate a subsequent developmental increase 
in its expression. This interpretation, however, tended to confuse the two 
issues of whether GC control the timing of PNMT appearance, or simply are 
required for its expression. 
In contrast to the results cited above, more recent experiments in 
dissociated cell culture have shown GC to be absolutely required for the 
initial appearance of PNMT (Seidl and Unsicker, 1989). Dose-response 
experiments further implied that the low levels of GC present in the fetal 
circulation prior to the surge in cortical steroidogenesis ought to be sufficient 
to induce PNMT prior to E17. These results suggested that although GC are 
necessary for the expression of PNMT, the appearance of these steroids is 
unlikely to control the time at which PNMT is initially expressed. However, 
this conclusion could not be critically tested because the chromaffin 
precursors were isolated at E16.3, only one day prior to the normal time of 
PNMT appearance. Hence the ability of GC to induce precocious appearance 
of PNMT in vitro could not be addressed. 
Radioligand binding studies to measure levels of GC receptor 
revealed a correlation between the time of PNMT appearance and the time 
at which levels of GC receptor first become detectable in embryonic 
chromaffin cells: receptors were measured at 5,OOO/cell on E17.3, but were 
not detectable on E16.3 (Seidl and Unsicker, 1989). Based on these results, the 
authors of these studies suggested that the delay in PNMT appearance can be 
attributed to a delay in the appearance of functional GC receptor within 
developing chromaffin cells. This would imply that chromaffin precursors 
are unresponsive to GC prior to E17. Such a conclusion, however, would 
preclude a role for GC in controlling the initial decision between the 
chromaffin and neuronal pathways which, based on the expression of 
markers in vivo (Anderson et ai., 1991) (Appendix III, this volume), occurs 
several days earlier in development. On the other hand, if GC do inhibit 
neuronal differentiation at early times, then why is the expression of PNMT 
delayed? 
Thus, while there is general consensus that GC influence chromaffin 
cell fate, the time at which these steroids first act on SA progenitors has 
remained a matter of controversy. The cell culture experiments in Chapter 2 
of the thesis were designed specifically to answer this question. Evidence is 
presented indicating that the delay in PNMT expression is due neither to a 
delay in the appearance of GC nor of its receptor. Rather, it is suggested that 
the timing of PNMT expression is controlled by cell-intrinsic changes in 
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progenitor cell responsiveness to Gc. Progenitor cells appear competent to 
respond to GC at early times in culture by inhibition of process outgrowth, 
but not by the expression of PNMf. Competence to induce PNMf appears 
to develop with time in culture, according to a cell autonomous schedule. In 
the absence of steroid, most SA progenitors differentiate into neurons, 
which cannot acquire competence to express PNMT (see Appendix II). GC 
inhibit this neuronal differentiation, and in doing so, act as a permissive 
factor for the acquisition of competence. In this way, the early, negative effect 
of GC is a prerequisite for its later, positive effect. Pharmacological data 
indicate that the early and late effects of GC are both mediated via type-II GC 
receptors, but may involve different interactions of the GC receptor. Such 
differences may explain how the same signal (GC) can have two temporally-
separated effects in this system. 
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GLUCOCORTICOIDS CONTROL TWO TEMPORALLY 
AND PHARMACOLOGICALLY DISTINCT EVENTS 
IN CHROMAFFIN CELL DIFFERENTIA TION* 
*A revised version of this manuscript, entitled "Changes in competence 
determine the timing of two sequential glucocorticoid effects on 
sympathoadrenal progenitors", by Arie M . Michelsohn and David J. 
Anderson, has been submitted for publication. 
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ABSTRACT 
We have shown that in vitro, sympathoadrenal progenitor cells 
differentiate to adrenal medullary chromaffin cells in two distinct stages: an 
early inhibition of neuronal differentiation, followed by a subsequent 
induction of PNMT. Both of these events are controlled by glucocorticoids 
(GC). Cells are initially competent to respond to GC by inhibition of process 
outgrowth, but not by the expression of PNMT. Competence to express 
PNMT is acquired with time in culture according to a cell-autonomous, 
steroid-independent schedule. When cells are cultured in the absence of GC, 
most differentiate to sympathetic neurons, which lose the ability to acquire 
competence to express PNMT. Thus, by inhibiting neuronal differentiation 
at early times in culture, GC are permissive for the acquisition of 
competence to induce PNMT at later times. Both the early, negative and 
later, positive effects of GC are mediated via type-II GC receptors, but are 
pharmacologically distinct, suggesting that the two effects of GC may 
involve different interactions of the GC receptor with the cellular 
transcription machinery. Such differences may explain how the two effects 
of GC in this system can be temporally separated. 
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INTRODUCTION 
The analysis of cell fate during vertebrate neural development has 
revealed that many progenitor cells are multipotent (Turner and Cepko, 
1987; Baroffio et ai., 1988; Holt et al., 1988; Wetts and Fraser, 1988; Bronner-
Fraser and Fraser, 1989). This is consistent with the idea that the choice of 
cell fate may be controlled, in many instances, by environmental signals 
(e.g., see Patterson, 1978). If this is indeed the case, the fact that different cell 
types develop on relatively well-defined schedules in turn implies that the 
timing of environmental influences may be an important aspect of the 
control of cell fate. However, there are relatively few systems in which this 
problem is amenable to study. The timing of glial cell differentiation has 
been extensively analyzed in the 02A lineage (Raff, 1989). These studies 
have revealed that the schedule of oligodendrocyte production is 
determined by a cell-autonomous clock, whereas that of type-2 astrocyte 
development is determined by the time of appearance of one or more 
instructive signals (Lilli en and Raff, 1990). One neurogenic progenitor cell 
that has been well-studied is the sympathoadrenal (SA) progenitor 
(Patterson, 1990). This neural crest-derived cell migrates either to the 
sympathetic ganglia, where it differentiates to sympathetic neurons, 
presumably under the influence of neurotrophic factors such as aFGF, bFGF 
and NGF (Anderson and Axel, 1986; Stemple et ai., 1988; Claude et ai., 1988; 
Birren and Anderson, 1990; Carnahan and Patterson, 1991), or to the adrenal 
gland, where it differentiates to chromaffin cells under the influence of 
adrenal corticosteroids (Unsicker et al., 1978; Doupe et al., 1985a,b; Anderson 
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and Axel, 1986; Carnahan and Patterson, 1991). While it is well-accepted that 
glucocorticoids (GC) are required for the maintenance of the chromaffin 
phenotype, the time at which these steroids first begin to exert their 
influence on SA progenitors has remained a matter of controversy 
(Anderson and Michelsohn, 1989; Ehrlich et al., 1989; Seidl and Unsicker, 
1989). 
Previous studies have used the expression of phenylethanolamine N-
methyl transferase (PNMT, the chromaffin-specific enzyme that converts 
norepinephrine into epinephrine) as a marker for the earliest effects of GC 
on chromaffin cell development (Bohn et a!., 1981; Teitelman et a!., 1982; 
Jiang et a!., 1989; Seidl and Unsicker, 1989). The major developmental onset 
of PNMT expression occurs at around embryonic day 17 (E17) in the rat 
(Teitelman et a!., 1979; Bohn et a!., 1981; Seidl and Unsicker, 1989). However, 
SA progenitors invade the developing adrenal gland as early as E13.5-E14.5 
(Pankratz, 1931; Lempinen, 1964; Bohn et a!., 1981). More recent studies 
indicate that such progenitors are already phenotypically distinct from their 
counterparts within sympathetic ganglia at this time (Anderson et a!., 1991). 
For example, at E14.5, cells in the adrenal anlage have retained expression of 
the marker SA-1 and have extinguished or failed to express neuronal 
markers, whereas cells in the ganglia primordia have extinguished SA-l and 
induced expression of the late neuronal marker, B2. Thus, the environment 
of the adrenal gland appears to influence the development of SA 
progenitors 2-3 days before the major onset of PNMT expression is detected. 
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These results have suggested that in vivo, chromaffin cell 
development proceeds through at least two stages: an early inhibition of 
neuronal differentiation, and a later induction of PNMT. This raises the 
question of whether GC mediate both events. Previous studies have shown 
that in vitro, GC are absolutely required for PNMT induction in embryonic 
SA progenitors (Anderson and Axel, 1986; Seidl and Unsicker, 1989). Studies 
on cultured postnatal chromaffin cells have shown, moreover, that GC 
block FGF- or NGF-induced neuronal differentiation (Unsicker et ai., 1978; 
Doupe et ai., 1985a; Stemple et ai., 1988). These data suggest that in vivo, GC 
might also act to inhibit neuronal differentiation, prior to inducing PNMT. 
However, recent data have suggested that the delayed appearance of PNMT 
reflects the time at which SA progenitors first acquire functional GC receptor 
(Seidl and Unsicker, 1989). If true, this would preclude the possibility that GC 
control the early inhibition of neuronal differentiation. If, on the other 
hand, GC do exert an early, inhibitory effect on SA progenitors, it raises the 
question of how the induction of PNMT is delayed. 
To address these issues, we have reconstituted the development of 
chromaffin cells from SA progenitors in vitro, and used this system to 
determine the time at which GC first influence cell fate. We have found that 
GC both inhibit neuronal differentiation and induce PNMT in SA 
progenitors, and that these two effects are temporally separated. Inhibition of 
process outgrowth is detected within 15 hours post-plating, whereas 
induction of PNMT is not detected in the majority of cells until 2-3 days in 
vitro, similar to its schedule of appearance in vivo. The delay in PNMT 
induction does not reflect the slow kinetics of accumulation of this protein, 
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but rather a delay in the ability of the cells to rapidly express this gene in 
response to Gc. The delay does not appear to involve a qualitative change in 
GC receptor expression, since both early and late effects appear to be 
mediated by the type-II GC receptor. However, the two effects are 
pharmacologically distinct, suggesting that they may involve different 
interactions of the GC receptor. If SA progenitors are permitted to 
differentiate into sympathetic neurons, the capacity to induce PNMT is 
irreversibly lost (Anderson et aI., 1991). Thus, the early inhibition of 
neuronal differentiation by GC is necessary to permit cells to subsequently 
acquire competence to express PNMT in response to steroid. This 
mechanism may serve to restrict the expression of epinephrine synthesis to 
those cells which have migrated to the adrenal gland. Taken together, these 
data reveal a two-step inductive process in chromaffin differentiation, in 
which the timing of the second event (PNMT expression) is controlled by 
neither the time of appearance of inducing signal, nor of its receptor, but 
rather by changes in the response properties of the cell. This mechanism fits 
well with recent insights into the molecular mechanisms of transcriptional 
regulation by the glucocorticoid receptor. 
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RESULTS 
PNMT is expressed on schedule by differentiating SA progenitors in vitro 
Migrating SA progenitors invade the developing adrenal gland on 
E13.5-E14.5 in vivo, but the expression of PNMT is not detected until several 
days later (Bohn et al., 1981; see also Appendices I and II). We first sought to 
determine whether PNMT could be expressed on schedule by isolated SA 
progenitors cultured in the presence of Gc. SA progenitors were isolated 
from E14.5 adrenal glands by fluorescence-activated cell sorting using 
monoclonal antibody HNK-1 (Abo and Balch, 1981). Freshly isolated HNK-
1+ cells express both TH (Fig. 1C) and SA-1 (Fig. 1A,B), an antigenic marker 
expressed by embryonic SA progenitors and by mature chromaffin cells 
(Carnahan and Patterson, 1991). By contrast, PNMT immunoreactivity is 
undetectable at the time of isolation (Fig. 1D). 
The cells so isolated were plated on a collagen/poly-lysine/laminin 
substrate in steroid-stripped medium (see Materials and Methods), 
supplemented with 1J.l.M corticosterone (CORT), or, in some experiments, 
the more potent agonist dexamethasone (DEX). Cultures were assayed for 
PNMT expression at either 1 (E14.5+1) or 3 (E14.5+3) days post-plating, by 
staining with a highly-specific anti-PNMT antibody (M. Bohn) and 
couterstaining with monoclonal anti-TH to identify the SA progenitor 
population. These assay points were chosen because they correspond to the 
equivalents of E15.5 and E17.5 in vivo, times when PNMT is expressed by 
few or most chromaffin cells, respectively (Appendix I). 
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In the presence of I~M CORT, the in vivo schedule of PNMT 
induction appeared to be reproduced in vitro. At EI4.5+1, very few of the 
TH+ SA progenitors expressed detectable PNMT (Fig. 2A,B; Fig. 3A, +1). By 
contrast, at EI4.5+3, corresponding to E17.5 in vivo, over 70% of cells 
expressed the enzyme (Fig. 2C,D; Fig. 3A, +3). Similar results were obtained 
using the more potent GC agonist DEX (Fig. 2E,G), although a slightly 
higher level of PNMT expression was detected at EI4.5+1 (Fig. 3B, +1). 
However, the overall staining intensity was much weaker at EI4.5+1 than at 
EI4.5+3, so that the quantitative data presented in Figure 3 overestimate 
PNMT expression at EI4.5+1 relative to that measured at EI4.5+3. The 
proportion of PNMT+ cells at EI4.5+3 did not increase with longer 
incubations (not shown), and is similar to that measured in vivo. No PNMT 
expression was detected at any times in cultures incubated without GC (Fig. 
4C), confirming the earlier observations of Seidl and Unsicker (1989). These 
data therefore indicate that in the presence of CORT, PNMT is expressed by 
isolated SA progenitors in vitro on a schedule that closely parallels the 
appearance of this enzyme in vivo. Moreover, the data indicate that GC are 
absolutely required for PNMT expression. 
Early inhibition of neurite outgrowth by GC 
Previous studies have suggested that the timing of PNMT appearance 
is controlled by the timing of the appearance of GC receptor at E17.3 (Seidl 
and Unsicker, 1989). This model predicts that SA progenitors should be 
ill 
unresponsive to GC prior to EI4.5+3 in vitro. We therefore sought an assay 
of GC-responsiveness in SA progenitors independent of the expression of 
PNMT. One such assay is the inhibition of neuronal differentiation. GC are 
known to inhibit process outgrowth from postnatal chromaffin cells 
(Unsicker et aI., 1978), and to suppress the expression of neuron-specific 
genes in PC12 cells (Stein et al., 1988). In the case of E14.S SA progenitors, 
l~M CORT strongly inhibited process outgrowth from these cells when 
cultured for 3 days in the presence of the steroid (Fig. 4A vs. D, B vs. E). We 
next asked whether the inhibition of process outgrowth by GC could be 
detected earlier than the appearance of PNMT. When isolated E14.S SA 
progenitors are cultured in the absence of steroid, the majority of the cells 
extend processes within the first 15 hours of culture (Fig. Sa). In the presence 
of either l~M CORT or DEX, this short-term process outgrowth is clearly 
inhibited (Fig. Sb,c). These qualitative observations were quantified at 24 
hours after plating (Figure Sd, NO ADD). Whereas over 60% of cell clusters 
bore processes in the absence of steroid, fewer than 30% of cell clusters did so 
in the presence of either WM CORT or DEX. (Note that this assay 
underestimates the inhibitory effect of steroid, since all cells in a cluster 
must lack processes in order for that cluster to be scored as round; see 
Materials and Methods.) 
To address the possibility that the early effect of steroid is to permit 
the survivai of a subpopulation of round cells rather than to inhibit neurite-
outgrowth, we carried out serial observations of identified living 
progenitors. The fates of 56 cells grown in the absence of DEX, and 62 cells 
grown in its presence, were monitored in low-density cultures over a three 
51 
day period. Cells were initially identified on gridded dishes at 4 hours after 
plating. After a total of 24 and 48 hours in culture, each cell was scored as 
round, process-bearing or dead. 47% of initially round cells cultured in the 
absence of steroid extended processes within the first 24 hours (Fig. 6 upper, 
A; Fig. 6 lower, -DEX,DAY 1), whereas in the presence of 111M DEX, 74% of 
such cells retained their round morphologies (Fig. 6 upper, B; Fig. 6 lower, 
+DEX, DAY 1). By day 2, 65% of initially round cells had extended processes 
in the absence of DEX (Fig. 6 lower, -DEX, DAY 2), while 76% remained 
round in the presence of steroid (Fig. 6 lower, +DEX, DAY 2). The fact that 
greater than 50% of the identified cells were round in the presence of DEX, 
and process-bearing in its absence, strongly implies that many individual 
cells are bipotential and that DEX therefore acts instructively to inhibit 
process outgrowth. In support of this interpretation, when cells that initially 
were process-bearing were followed, in many cases a retraction of such 
processes was observed within the first 24 hours of culture in DEX (Fig. 6 
upper, C). 
Thus, the analysis of both identified cells and cell popUlations 
supports the idea that GC exert an early inhibitory effect on neuronal 
differentiation in E14.5 SA progenitors. By contrast, little or no PNMT 
expression is detected in this cell population during the first 24 hours of 
culture (E14.5+1). Taken together, these results imply that SA progenitors at 
E14.5 possess functional glucocorticoid receptors, and that the delay in the 
appearance of PNMT is therefore unlikely to be due to a delay in the 
expression of such receptors. 
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The adrenal gland contains sufficient GC to inhibit neuronal differentiation 
at E14.5 
The foregoing results indicate that in vitro, GC exert two temporally-
separable effects on chromaffin cell differentiation. As early as E14.5, the 
steroids are able to inhibit neuronal differentiation. Two to three days later, 
expression of PNMT is detected, that is absolutely GC-dependent. If GC 
mediate an early inhibition of neuronal differentiation in vivo, then the 
E14.5 adrenal gland should contain sufficient concentrations of endogenous 
steroids to mediate this effect. Previous studies of GC content in the fetal rat 
adrenal gland measured a large surge in steroid levels between E16.5 and 
E17.5, by radioimmunoassay (Teitelman et ai., 1982). However, these studies 
did not examine the content of GC two days earlier in development, when 
SA progenitors first invade the adrenal gland. To address this issue, the 
levels of various steroid hormones in fetal adrenal glands between E14.5 and 
E17.5 were analyzed by RIA (see Materials and Methods). 
Micromolar or sub-micromolar levels of CORT, progesterone (PROG) 
and ll-deoxycorticosterone (DXC) are already present in developing adrenal 
glands at E14.5 (Table 1). Consistent with previous studies (Roos, 1967; 
Teitelman et al., 1982), the levels of all three steroids increase substantially 
over the next several days. CORT is the predominant steroid present at all 
stages examined, although the relative concentration of PROG is higher at 
E14.5. DXC and CORT were undetectable in sympathetic ganglia, muscle or 
brain at E14.5 (Table 1), indicating that these steroids are specifically 
concentrated in the adrenal gland. Although CORT levels at E17.5 {the time 
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of PNMT induction) are extremely high, the concentrations of the steroid 
present at E14.5 are easily sufficient to inhibit neuronal differentiation in 
vitro (see Fig. 7, below). Moreover, they are also sufficient to induce PNMT 
in vitro (see below), further supporting the idea that the schedule of PNMT 
appearance in vivo is not controlled by the time of appearance of GC within 
the adrenal gland. 
Both effects of GC on SA progenitors are mediated by type-II GC receptors, 
but are pharmacologically separable 
Our in vitro observations raise the question of how the same 
inducing signal, GC, can mediate two temporally distinct effects in the same 
responding cell type. One possible explanation is that the responses are 
mediated by different types of GC receptors; studies of the steroid receptor 
gene superfamily have indicated that there are at least two GC receptors, 
called type I and type IT (see, eg., Evans and Arriza, 1989). To address this 
issue, we first examined the dose-response characteristics of the two different 
GC effects, after three days of exposure to the steroid. A significantly lower 
concentration of GC was required to inhibit process outgrowth than was 
required to induce PNMT (Fig. 7 A). Half-maximal inhibition of process 
outgrowth was achieved at a CORT concentration of 40nM, whereas half-
maximal PNMT expression required ZOO-ZSOnM CORT. This difference was 
also apparent when DEX was used as the glucocorticoid (Figure 7B). 
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Despite this difference in dose-response profiles, the two effects of GC 
can be inhibited by the potent type-II GC receptor antagonist RU38486 
(Teitelman, et aI., 1982; Jung-Testas and Baulieu, 1983; Moguilewsky and 
Philibert, 1984; Nawata et aI., 1988). The induction of PNMT by lOOnM DEX 
was completely blocked by only a S-fold excess of. RU38486 (Fig. 7C, filled 
symbols). At this concentration of DEX, a IS-fold excess of RU38486 also 
blocked about 60% of the process-outgrowth inhibition (Fig. 7C, open 
symbols). However, 100nM DEX is an order of magnitude above the 
saturating dose for this inhibitory effect (Fig. 7B). At 10nM DEX, a near-
saturating dose for process-outgrowth inhibition, a 50-fold excess of RU38486 
was able to block 80% of the inhibitory effect of DEX (Fig. 7D, filled symbols). 
The inability of RU38486 to completely block the DEX-inhibition of process-
outgrowth reflects the fact that, at high concentrations, this GC receptor 
antagonist on its own displays a partial agonist activity for this response; in 
other words, it inhibits process outgrowth (Fig. 70, open symbols). Indeed, 
the residual 20% activity observed in 10nM DEX+I000nM RU38486 (Fig. 70, 
filled symbols) can be accounted for by the agonist (i.e., process outgrowth-
inhibitory) activity seen with RU38486 alone (Fig. 7D, open symbols at 
1000nM RU38486). Such a partial agonist activity of RU38486 at high 
concentrations has been observed for steroid-inducible responses in other 
systems. Despite these quantitative differences in the efficacy of inhibition by 
a specific antagonist, the data support the idea that both the inhibition of 
process-outgrowth, and the induction of PNMT, are mediated via type-II GC 
receptors. Further support for this conclusion comes from the observation 
that neither process-outgrowth inhibition nor PNMT induction were 
blocked by a 50-fold excess of the type-I GC receptor antagonist RU28318 
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(Torelli et aI., 1982; Ratka et aI., 1989) (Table II). Moreover, a low 
concentration (SOnM) of the specific type-II GC receptor agonist RU26988 
(Teutsch et al., 1981) had comparable efficacy to DEX in both assays (Table II). 
One consequence of the different dose-response profiles observed is 
that low concentrations of either CORT or DEX are able to inhibit process 
outgrowth, without inducing PNMT expression (Fig. 7 A,B, open symbols). 
This in turn suggests that weak agonists of the GC receptor could have 
similar effects. We therefore examined the activity of PROG and DXC, two 
biosynthetic precursors to CORT which are known to be weak agonists of the 
GC receptor (Samuels and Tomkins, 1970), in the two bioassays. Inhibition of 
process outgrowth was observed using both DXC and PROG, whereas PNMT 
induction was not (Fig. 8 and Table II). PROG at lJlM was 61 % as effective as 
DEX in inhibiting process outgrowth, but greater effects were not observed at 
higher concentrations (not shown). That this effect of PROG is not mediated 
via the progesterone receptor (PR) is suggested by the fact that aPR-specific 
agonist, RS020 (Philibert and Raynaud, 1973; Philibert et aI., 1977; Haslam 
and Shyamala, 1979), showed little inhibition of process outgrowth 
compared to PROG, although it is more specific for the PR (Table II). The 
specificity of the PROG and DXC effects is further indicated by the fact that 
testosterone and J3-estradiol had no significant effects in this system (Table 
II). These data therefore indicate that progesterone, a biosynthetic precursor 
of corticosterone present in the adrenal gland at E14.S (Table 1), is able to 
inhibit the neuronal differentiation of SA progenitors without inducing 
PNMT. The s.eparation of these two effects is explained by the weak cross-
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reactivity of progesterone towards the type-II GC receptor, and the lower 
threshhold for the inhibitory response. 
The delay in PNMT appearance reflects the acquisition of competence to 
express the enzyme, and not simply the slow kinetics of protein 
accumulation 
The foregoing data indicate that both process outgrowth inhibition 
and PNMT induction are likely to be mediated by the same type of GC 
receptor. The delay in PNMT appearance is therefore unlikely to be due to 
the appearance of a novel GC receptor. Another explanation is that the 
timing of PNMT appearance is controlled by the acquisition or loss of other 
molecules which interact with the GC receptor to control expression of 
PNMT. Such a mechanism would in effect constitute a cell-autonomous 
"clock". Alternatively, PNMT expression could be initiated from the start of 
the culture period, and the failure to detect it before E14.5+3 would simply 
reflect the slow kinetics of accumulation of this enzyme to 
immunocytochemically-detectable levels. If the latter were the case, then 
detectable PNMT immunoreactivity should appear in cultures with similar 
kinetics, irrespective of the time at which cells are initially exposed to Gc. 
To test this prediction, we compared the expression of PNMT in cells 
exposed to CORT for the first 24 hr of culture, to that in cells grown for two 
days in the absence of steroid and then exposed to CORT for the last 24 hr of 
culture. Thus, in both conditions, cells were assayed for PNMT expression 
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after a 24 hr exposure to CORT, but the time at which this exposure was 
initiated was different. As described earlier, when CORT was added at the 
time of plating and PNMT assayed at E14.5+1, very few of the cells were 
positive, and only weakly so (Fig. 9A,B; Fig. IDA, 24C). In striking contrast, 
when CORT was added at E14.5+2, PNMT was clearly detectable in 23% of 
cells 24 hr later (Fig. 9C,0; Fig. IDA, 48N/24C). Thus, the induction of PNMT 
occurs more rapidly in the third day of culture, although no steroid was 
present for the first two days. Moreover, this effect is underestimated by 
measuring the percentage of total cells that are PNMT-positive (Fig. IDA). 
This is because a high proportion of SA progenitors commit to neuronal 
differentiation in the first 48 hours of culture (Fig. 6; Fig. 90), and such 
committed neuroblasts are unable to express PNMT in response to GC 
(Anderson et ai., 1991). When the percentage of PNMT-positive cells is 
calculated for only those cells that retained a round morphology during the 
first 48 hours of culture (Fig. lOB, 48N /24C), over 65% of such cells are 
immunoreactive for PNMT upon a subsequent 24 hr exposure to CORT (Fig. 
9C,0, arrows; Fig. lOC, 48N /24C). This value is within 25% of that measured 
for cells grown continuously in CORT for three days (Fig. 9G,H; Fig. WC, 
72C). By contrast, 5-fold fewer round cells express PNMT when steroid is 
added for the first 24 hours of culture (Fig. WC, 24C). 
These data suggest that when presentation of CORT is delayed for 2 
days, subsequent PNMT expression only occurs in those cells which escape 
neuronal differentiation during the delay period. This implies that the total 
number of PNMT+ cells should be increased by a treatment that would 
inhibit neuronal differentiation without inducing PNMT during the delay 
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period. Such a requirement is filled 'by progesterone (see above). We 
therefore compared the percentage of PNMT + cells that developed after a 
delayed exposure to CORT in cultures preincubated for two days with or 
without I~M progesterone. As expected, pretreatment with PROG clearly 
increased the percentage of round cells compared to cultures grown in 
control medium (Fig. 9D,F; Fig. lOB, compare 48N /24C to 48P /24C), 
reflecting the ability of this steroid to inhibit neurite outgrowth (see above). 
Concomitantly, preincubation in PROG yielded an almost two-fold increase 
in the percentage of total cells expressing PNMT upon a subsequent 24 hr 
exposure to CORT (Fig. 9C,E; Fig. lOA, 48P /24C). However, the percentage of 
round cells expressing PNMT was similar whether or not PROG was 
included during the preincubation (Fig. 10C). These results are consistent 
with the idea that progesterone can "rescue" cells that would otherwise have 
differentiated into neurons, and maintain their program of chromaffin 
differentiation. 
Taken together, these data indicate that most cells that have not yet 
committed to neuronal differentiation during the first 48 hr of culture are 
capable of rapidly expressing high levels of PNMT upon a subsequent 
exposure to CORT for 24 hr. By contrast, the majority of freshly-isolated 
E14.5 SA progenitors fail to display such a rapid PNMT induction. This 
difference suggests that the delay in PNMT appearance observed upon 
continuous exposure to CORT (Fig. 2A) does not reflect a slow rate of PNMT 
accumulation. Rather, SA progenitors acquire the capacity to rapidly express 
PNMT in response to CORT, as they develop in culture. We refer to this 
capacity as "competence". The fact that PROG increases the proportion of 
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cells that acquire competence, but cannot itself induce PNMT, further argues 
that competence reflects an underlying process distinct from the 
accumulation of immunoreactive enzyme. The acquisition of competence 
can occur in the absence of steroid, and follows a cell-autonomous schedule. 
I'D 
DISCUSSION 
Migrating SA progenitor cells invade the adrenal gland primordium 
at E13.S-E14.S and choose a chromaffin fate under the influence of the 
adrenal microenvironment. We have shown that chomaffin cell 
development proceeds through at least two distinct stages: an early 
inhibition of neuronal differentiation, and a subsequent induction of PNMT 
expression. We have reconstituted this sequence of events in vitro, using a 
purified population of E14.S SA progenitor cells, and have shown that both 
stages of differentiation are dependent upon GC and are mediated by the 
type-II GC receptor. The two temporally-separated effects of GC are 
pharmacologically distinct, implying that they may involve qualitatively or 
quantitatively different interactions of the GC receptor. We have shown 
further that the delay in PNMT appearance does not reflect simply the slow 
kinetics of enzyme accumulation, but rather a timed, cell-intrinsic process 
that is necessary, in addition to GC, for PNMT expression. We propose, 
therefore, that the timing of PNMT appearance reflects a gain of competence 
for induction of this enzyme by Gc. Although the molecular mechanisms 
underlying competence in this system are not yet known, it presents a clear 
case in which the timing of an inductive event (the expression of PNMT) is 
determined neither by the time of appearance of the inducing signal, nor of 
its receptor. 
GC are required for the initial appearance of PNMT, but do not control its 
timing 
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The expression of detectable PNMT-immunoreactivity in SA 
progenitor cells is absolutely dependent upon the addition of exogenous Gc. 
These results are in agreement with the recent studies of Seidl and Unsicker, 
who assayed PNMT expression in chromaffin cell precursors isolated at 
E16.3, using three independent methods of varying sensitivities (Seidl and 
Unsicker, 1989). The conclusion that GC are required for PNMT expression 
does not necessarily imply, however, that GC control the timing of this 
expression. Early studies of fetal steroidogenesis revealed a surge in GC 
synthesis whose timing seemed to correlate with the developmental 
induction of PNMT (see also Table I). This observation, taken together with 
the fact that PNMT expression is dependent upon GC in the adult 
(Wurtman and Axelrod, 1966; Ciaranello and Black, 1971) originally 
suggested that the surge in corticosterone production by the adrenal cortex 
controls the timing of PNMT appearance. However, our in vivo assays of 
adrenal steroid content indicate that micromolar or sub-micromolar 
concentrations of steroid are already present in the adrenal at E14.5, two days 
before the surge occurs, consistent with the previous studies of Roos (1967). 
These concentrations are more than sufficient to induce PNMT in vitro, in 
agreement with the studies of Seidl and Unsicker (1989). Nevertheless, 
induction of PNMT in vivo is delayed until E16.S-E17.S. A similar delay is 
observed in vitro, despite the presence of GC from the time of plating. 
Therefore, the timing of PNMT appearance is not controlled by the time of 
the appearance of Gc. 
Earlier studies led to the conclusion that GC are not required for the 
initial appearance of PNMT during development (Ehrlich et ai., 1989). This 
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conclusion was based upon three observations: 1) the inability of 
intrauterine injections of GC prior to E17 to induce precocious PNMT 
expression in vivo (Bohn et ai., 1981); 2) the expression of PNMT on 
schedule in organ cultures of adrenal glands in the absence of exogenously 
added steroid (Teitelman et ai., 1982); and 3) the observation that PNMT is 
detectable in vivo, albeit at low levels and in a minority of cells, two days 
prior to the surge in adrenal corticosteroid synthesis (Ehrlich et ai., 1989). 
Our data indicate that GC are required for the initial expression of PNMT, 
but do not control the timing of PNMT appearance. None of these earlier 
studies is inconsistent with this conclusion. For example, the inability to 
induce precocious PNMT expression in vivo by steroid injections is 
consistent with our demonstration that most SA progenitors are not 
competent to express PNMT at E14.5. In the case of the organ culture 
studies, the whole adrenal explants used contained an abundance of GC-
producing cortical cells, which could provide a sufficiently concentrated 
source of endogenous GC to induce PNMT expression in the absence of 
exogenous steroid. Finally, since E14.5 adrenal glands contain concentrations 
of GC sufficient to induce PNMT (Table I) two days before the surge in 
cortical steroidogenesis, the early detection of PNMT in a small number of 
cells does not constitute evidence for the GC-independence of PNMT 
expression, as previously suggested. 
Our data indicate that the majority of SA progenitor cells display a 
rapid biological response to GC -- neurite outgrowth inhibition -- 24-48 
hours before they express PNMT. Our pharmacological data suggest that 
both the early and late effects of GC are mediated by type-II GC receptors. 
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Thus, although our results confirm the previous demonstration by Seidl 
and Unsicker that GC are required for PNMT expression, they do not 
support their conclusion that the timing of PNMT expression is controlled 
by the time of the appearance of the GC receptor. The failure of Seidl and 
Unsicker (1989) to detect receptors prior to E17.3 by radioligand binding could 
reflect a low sensitivity of their assay, or a difference in receptor affinity at 
E16.3 versus E17.3. Whatever the case, SA progenitors appear to possess 
functional GC receptors several days prior to the appearance of PNMT, 
suggesting that other mechanisms control the timing of the onset of 
epinephrine synthesis. 
The timing of PNMT appearance is controlled by a cell autonomous "clock" 
We have shown that most E14.5 SA progenitor cells are unable to 
respond to GC by rapid induction of PNMT within the first 24 hrs of culture. 
A higher proportion of cells acquires the ability to express PNMT, over time 
in culture. This observation suggests that the delay in PNMT appearance 
that is observed in vitro and in vivo is unlikely to simply reflect the slow 
kinetics of enzyme accumulation. Rather, SA progenitors appear to acquire 
competence to express PNMT during their development in culture. 
Previous studies in other systems provide precedent for several 
mechanisms that could underlie the acquisition of competence. For 
example, in avian liver, five different yolk genes become inducible by b-
estradiol at different ages (Evans et ai., 1987). Full competence to induce 
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different genes is acquired gradually over time, as cells autonomously 
upregulate levels of estrogen receptor (ER) via an estrogen-independent 
mechanism. By analogy, perhaps process-outgrowth inhibition in SA 
progenitor cells requires a smaller number of GC receptors per cell than does 
PNMT induction. In that case, the acquisition of competence to express 
PNMT might be explained by an increase in the concentration of GC receptor 
to a critical threshhold. Consistent with this idea, an increase in the number 
of GC receptors per cell has been observed to occur concomitant with the 
expression of PNMT (Seidl and Unsicker, 1989). 
An alternative mechanism for the acquisition of competence is 
changes in the expression of other regulatory factors that act in concert with 
the GC receptor to control PNMT gene transcription (see below). Studies of 
mice homozygous for deletions near the albino locus on chromosome 7 
provide genetic evidence that factors other than GC receptor are required for 
the induction of some steroid-responsive genes (DeFranco et ai., 1991). 
Hepatocytes in these mutant mice lack GC-inducibility of several liver-
specific genes, yet possess wild type numbers of functional GCR, suggesting 
the absence of an accessory factor. Perhaps an analagous accessory factor 
controls competence to induce PNMT in chromaffin cells. In support of this 
idea, transfected PNMT-~-galactosidase constructs containing a GRE are not 
expressed in PC12 cells that contain functional GC receptors, but are 
expressed in adult chromaffin cells (Ross et ai. , 1990). This suggests that 
PNMT expression is dependent upon additional factor(s} differentially 
expressed in PC12 cells and chromaffin cells. The timing of PNMT 
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expression during development could then reflect the time at which such a 
regulator accumulates (or decays) to threshhold levels in SA progenitors. 
The early and late effects of GC may involve different interactions of the GC 
receptor 
SA progenitors display an early inhibition of process outgrowth in 
response to GC that precedes the induction of PNMT. Our data suggest that 
these two effects of GC, though both mediated via type-II GC receptors, are 
pharmacologically distinct. Lower doses of GC are required for maximal 
inhibition of process-outgrowth than for PNMLinduction. In addition, 
weak GCR agonists, such as progesterone, produce significant amounts of 
process-outgrowth inhibition without inducing PNMT. Finally, RU38486 
displays full antagonist activity towards PNMT induction, but shows partial 
agonist activity towards process-outgrowth inhibition. Pharmacological 
differences in steroid-inducible responses within the same cell type have 
been seen in other systems. For example, tyrosine aminotransferase (TAT) 
induction in the FU5-5 rat hepatoma cell line occurs at an approximately 5-
fold lower DEX concentration than is required for the induction of other 
steroid-inducible genes. Moreover, RU38486 displays partial agonist activity 
towards TAT induction, but behaves as a pure antagonist with respect to the 
induction of other genes such as glutamine synthetase or an MMTV-
reporter gene construct (Mercier et ai., 1983; Mercier et ai., 1986; Simons et 
ai., 1989). It has been suggested that such differential responsiveness of 
various genes to GC may reflect differences in the accessory factors that act in 
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concert with the GC receptor to regulate transcription at a given promoter 
(Meyer et al., 1990). 
Recent studies have identified several factors that interact with the 
GC receptor to regulate transcription. For example, the GREs of at least some 
steroid-regulated genes overlap recognition elements for transcription 
factors in the AP-1 family. Steroid inducibility at such "composite GREs" has 
been shown to be dependent upon interactions between the GC receptor and 
c-fos and/or c-jun (Diamond et aI., 1990). The affinity of a liganded GC 
receptor for such a composite GRE may therefore reflect not only its affinity 
for DNA, but also its affinity for other proteins bound at or near the site. 
Different steroid-inducible genes may therefore have different affinities for 
liganded GC receptor. According to this idea, the differing dose-response 
curves for the positive and negative effects of GC on SA progenitor cells 
could reflect the fact that these two effects require different concentrations of 
liganded receptor in the cell. 
PNMT expression requires an earlier developmental decision 
It has been well established that the fate of SA progenitor cells is 
controlled by environmental signals, and that GC promote chromaffin 
differentiation. Our observations reveal that GC control two distinct steps in 
chromaffin cell development: not becoming a neuron, and expressing 
PNMT. These steps are temporally and pharmacologically separable. 
Moreover, they are related to each other, since cells that differentiate into 
neurons are unable to express PNMT. Thus, GC appear to be necessary at 
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early times in chromaffin development to prevent cells from differentiating 
into neurons. We found that progesterone and ll-deoxycorticosterone, two 
biosynthetic precursors of corticosterone, are also able to inhibit the 
neuronal differentiation of SA progenitors. The presence of progesterone 
and ll-deoxycorticosterone in the adrenal gland at E14.5 (Table I) suggests 
that these steroids may also contribute to inhibiting the neuronal 
differentiation of migrating SA progenitors. In this way, an early action of 
adrenal corticosteroids on SA progenitors is a necessary prerequisite for a 
later inductive effect of these hormones (Fig. 11). Such a mechanism would 
explain why PNMT is expressed by cells in the adrenal gland and not by 
neurons in the sympathetic ganglia, even though the ganglia are exposed to 
a transient surge in circulating GC levels at E17.5 . 
In vitro, a small proportion of cells escapes neuronal differentiation 
in the absence of GC and is able to express PNMT upon subsequent exposure 
to steroid. This observation would predict that a few cells in the sympathetic 
ganglia in vivo might transiently express PNMT upon exposure to a high 
level of corticosterone. In fact, a transient burst of PNMT expression is 
observed in the superior cervical sympathetic ganglia in vivo at E17.5, 
coincident with the surge in circulating GC (Bohn et al., 1982). Such 
ganglionic PNMT expression appears restricted to SIF cells, which are not yet 
committed to neuronal differentiation (Doupe et al., 1985b). These 
observations therefore support the idea that the acquisition of competence is 
not dependent upon the presence of GC, although it is more likely to occur 
in the presence of steroid. 
ffi 
Our results may also help to explain why some chromaffin cells do 
not express PNMT, even though they are located in the steroid-rich adrenal 
gland (Hillarp and Hokfelt, 1953; Eranko, 1955). The fact that the acquisition 
of competence is not a steroid-dependent event implies, conversely, that 
some cells may not acquire competence even in a high concentration of Gc. 
Indeed, we observe that 20-30% of SA progenitors in vitro do not express 
PNMT, even in the presence of 1mM CORT. This percentage is similar to 
the proportion of PNMT-negative chromaffin cells in vivo (Doupe et al., 
1985b). Thus, despite their location in the GC-rich environment of the 
adrenal gland, some SA progenitors may not acquire competence, and 
therefore would fail to express PNMT. The reason why some chromaffin 
cells would fail to acquire competence is not clear. However, as SA 
progenitors differentiate along the competing neuronal pathway, they reach 
a point at which they can no longer acquire competence (Fig. 11) (Anderson 
et aI., 1991). It may be that a subset of SA progenitors in the adrenal gland 
advances along the neuronal pathway to this critical pont, without 
undergoing overt neuronal differentiation. Consistent with this idea, 
PNMT-negative chromaffin cells express some neuronal markers, such as L1 
and the calcium-binding cerebellar Purkinje cell-specific protein (spot-35), 
not expressed in PNMT-positive chromaffin cells (Kondo et aI., 1985; 
Langley, 1991). The mechanisms that control this heterogeneity in the 
chromaffin cell population are not clear. 
The precise molecular mechanisms that underlie the temporal 
separation of GC effects on SA progenitor cells await future study. However, 
our results suggest that the developmental regulation of PNMT expression 
ffi 
is likely to occur through a more complex mechanism than previously 
considered. This mechanism involves cell-autonomous changes in the 
response properties of progenitor cells to Gc. Our data thus underscore the 
possibility that the timing of inductive events can be controlled by 
mechanisms other than the appearance of an inducing signal or its receptor. 
Moreover, they emphasize that cell fate may involve progressive 
mechanisms consisting of temporally ordered, discreet steps. The SA lineage 
may provide a frutiful system for investigating such mechanisms in 
molecular detail. 
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MATERIALS AND METHODS 
Isolation, Plating and Culture of Sympathoadrenal Progenitor Cells 
Staged embryos were removed from timed-pregnant Simonson Albino rats 
(Simonson Labs). The morning following an overnight breeding was 
considered day 0.5 of gestation. Dissociated suspensions of adrenal tissue 
were prepared as previously described (Anderson and Axel, 1986). 
Sympathoadrenal progenitor cells were isolated by fluorescence-activated 
cell sorting using the monoclonal antibody HNK-1, as previously described 
(Anderson et. al., 1991). Isolated HNK-1+ cells were plated at a density of 
approximately 400 cells/mm2 into 4 mm-diameter cloning rings placed on 
the surface of 24-well tissue culture plates that had been previously coated 
with a collagen/poly-D-lysine/laminin substratum and cultured in US-C02 
complete medium, as previously described (Anderson and Axel, 1986), 
except that FBS that had been previously stripped of endogenous steroids 
was substituted for rat serum. For single-cell tracking experiments, cells were 
plated at a density of approximately 25 cells/mm2 in 35-mm dishes. Cells 
were identified at 4 hours post-plating and their positions marked by means 
of a gridded coordinate system embossed in the bottom of the dish using a 
BB press. Cells were photographed at this time and after a total of 24 and 48 
hours in culture. When included, the steroids used in this study were 
diluted from stock solutions of ImM in 95% ethanol. Dexamethesone, 
corticosterone, progesterone, II-deoxycorticosterone, pregnenolone, 
testosterone and ~-estradiol were purchased from Sigma. RU26988, RU28318 
and RU38486 were the kind gifts of D. Philibert and J. Raynaud, Roussel-
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Uclaf (Rommainville, France). R5020 (promegestone) was purchased from 
New England Nuclear. 
Immunocytochemical and Morphological Assays 
Cells were fixed in 4% formaldehyde in 25mM HEPES-buffered MEM + 5% 
sucrose for 10 minutes at room temperature. For quantitative analysis of 
PNMT and TH expression, cells were preblocked for 30 min. at room 
temperature in a solution containing O.5M NaCl, O.lM sodium phosphate 
buffer (pH 7.4), 10% horse serum, 3% NGS and 0.3% NP-40. Cells were then 
incubated with a monoclonal antibody directed against TH (Boeringer-
Mannheim) used at a dilution of 1:100, and a rabbit polyclonal antiserum to 
PNMT (the kind gift of Dr. Martha Bohn), used at a dilution of 1:1000, 
overnight at 40C. Immunostaining was developed using FITC-Goat-anti-
Mouse IgG and Rhodamine-Goat-anti-Rabbit antibodies (TAGO). Cells were 
counterstained with DAPI (Sigma) to verify the number of cells present in 
the tight clusters of cells which were often present in the cultures. PNMT 
expression was assayed as the percentage of TH+ cells that were also PNMT+ 
(TH is a specific marker of all cells in the sympathoadrenal lineage). >300 
cells were counted for each determination. For double-labelling with HNK-l 
and SA-1 antibodies, HNK-l+ cells isolated by FACS were fixed and 
subsequently preblocked in PBS+ 1 %NGS+0.1 % NP-40 for 30 minutes at 
room temperature, incubated with SA-1 monoclonal antibody ascites fluid 
(the kind gift of Dr. Josette Carnahan) at a dilution of 1:250 overnight at 40C, 
and developed using a rhodamine-Goat-anti-mouse IgG secondary antibody 
(Southern Biotech). To reduce non-specific binding, dilutions of this 
secondary antibody were precleared as described previously (Anderson et. al., 
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1991). Controls lacking primary antibody exhibited no specific staining. For 
quantifying the extent of process-outgrowth, a cell-cluster was defined as 
"process-bearing" if any cytoplasmic extension could be detected originating 
from the cluster at 200x magnification. >200 clusters were counted for each 
determination. It was not possible to determine whether every cell in a 
cluster was process-bearing, because the tight clumping of cells precluded 
assignment of processes to individual cells. Nonetheless, for the purposes of 
this study, this measurment represents a highly stringent criterion, in that 
only clusters containing exclusively round cells were counted as non-
process-bearing. Any systematic error introduced by this method would, if 
anything, underestimate the inhibition of neurite-outgrowth produced by 
GC, because only clusters in which all cells lacked processes would be scored 
as round. 
For comparison of the relative effects of various steroids on process 
outgrowth inhibition or PNMT expression, values are presented as the 
percent of maximal activity, where maximal activity is the effect measured 
after culturing in 1 11M DEX for 3 days, the "standard" condition. The 
standard condition was performed in parallel with test conditions in each 
independent run of an experiment, as was a control incubation in the 
absence of steroid. This method served to normalize the data for variations 
in the extent of steroid effects observed from plating to plating, and 
permitted the pooling of data from different platings and different 
experiments. In the case of PNMT induction, the average maximal activity 
was 84% PNMT+ cells (22 separate determinations from 13 different platings) 
(see Fig. 3). Since no PNMT was detected when cells were grown in the 
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absence of steroid, the % of maximal PNMT induction observed in a given 
test condition was calculated as (%PNMT+ cells in test condition/%PNMT+ 
cells in the standard condition) x 100%. 
In the case of process outgrowth inhibition (poi), the inhibition 
produced by a given test steroid (%poitest) was defined as: 
%pONA _ %potest 
%poitest = "' NA x 100% (1) 
70PO 
where %poNA = percent process-bearing clusters (po) in control medium 
(No Addition), and %potest = percent process-bearing clusters in the 
presence of test steroid. This metric normalizes the data to the extent of 
process outgrowth obtained in control medium, which varies slightly from 
plating to plating (range = 70% - 93% for 13 independent platings). DEX (at > 
100nM) always produced the maximal inhibition of process outgrowth of 
any steroid tested, but the extent of inhibition also varied from plating to 
plating (range = 61 % - 87% for 13 independent platings). Therefore, as in the 
case of PNMT induction the process outgrowth inhibition produced by a 
given dose of test steroid in any experiment was always normalized to the 
inhibition produced by 111M DEX in the same experiment. The data are 
therefore presented as the relative efficacy of a given steroid in comparison 
to 1mM DEX: 
%maximal inhibition test 
%poitest 
"' .DEX x 100% 
10 pOl 
(2) 
Substituting the expression for %poi from equation 1, this parameter can be 
calculated directly from the raw numbers obtained in an experiment as: 
%maximal 
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%pONA _ %potest 
inhibition test = 01 NA 01 DEX x 100% 
YOPO - YOPO 
(3) 
For example, if in a particular experiment, %poNA = 80%; %poDEX = 30%; 
and %pocorticosterone = 40%, then %maximaI inhibitioncorticosterone = [(80% -
40%)/(80% - 30%)] x 100% = 80%; in other words, in this experiment, 
corticosterone was 80% as effective as (1~M) DEX at inhibiting process 
outgrowth. 
Determination of Steroid Concentrations by Radioimmunoassay 
Dissected tissue from sources indicated in the text were frozen in liquid 
nitrogen and shipped on dry ice to the Nichols Institute (San Juan 
Capistrano, CA) for analysis of progesterone, ll-deoxycorticosterone and 
corticosterones content by RIA. The procedures used by the analytic facility 
were in-house modifications of established protocols (Abraham et aI., 1971; 
Nabors et aI., 1974; Antonipillai et aI., 1983), using highly specific antibodies. 
Sensitivity of the assays on tissue samples was estimated by the Nichols 
Institute to be in the O.l~M range for the three steroid examined. As a test of 
the assays' specificity and accuracy, a series of solutions containing known 
concentrations of corticosterone, ll-deoxycorticosterone, progesterone and 
testosterone, in various combinations, were sent for analysis along with the 
experimental samples. Results of the assays on the known solutions were 
within 20% of the correct values for all samples examined, and no cross-
reactivity between steroids was observed. 
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Table I. Steroid concentrations in developing adrenal glands as determined 
by radioimmunoassay. 
Adrenal glands from rat embryos between E14.5 and E17.5 were dissected, 
frozen in liquid nitrogen, and shipped on dry ice to the Nichols Institute for 
analysis of steroid content by RIA, as described in Materials and Methods. 
Sympathetic ganglia, brain and forelimb muscle were also dissected, as 
controls. Samples consisted of pooled tissue from 35,25,20,10,20,15 and 15 
embryos from E14.5 adrenal, E15.5 adrenal, E16.5 adrenal, E17.5 adrenal, E14.5 
sympathetic ganlia, E14.5 brain and E14.5 forelimb muscle, respectively. 
Values for concentrations of progesterone (PROG), ll-deoxycorticosterone 
(DXC) and corticosterone (CORT) were reported to us in units of ng steroid/ g 
tissue. These values were then calculated as ~M concentrations assuming a 
tissue density of 1 g/ml. We estimate that this value for tissue density is 
within 10% of the actual value, since the tissue samples sink in distilled 




Steroid Concentrations in Embryonic Adrenal Glands 
as Oetermined by Radioimmunoassay 
CONCENTRATION (11M)' 
Sample CORT OXC PROG 
E14.5 Adrenal 3 0.4 0.7 
E15.5 Adrenal 20 0.6 1.1 
£16.5 Adrenal 200 7.2 2.4 
E17.5 Adrenal 500 100 25 
E14.5 Muscle NO' NO' NO' 
Brain NO' NO' 0.7 
Symp. Ganglia NO' NO' NO' 
'NO=not detectable 
' see legend for calculation 
71 
Table II. Effect of synthetic and endogenous steroids on process-outgrowth 
and PNMT induction in SA progenitors cells in culture. 
EI4.S HNK-l+ SA progenitor cells were cultured in the absence (No 
Addition) or the continued presence of various synthetic (A) or naturally 
occuring (B) steroids, at the indicated concentrations, for 3 days (until 
EI4.5+3), at which time the cultures were assayed for process-outgrowth and 
PNMT expression as described in Materials and Methods. Values are 
expressed as the % of maximal activity, relative to IJlM dexamethesone 
(=100% process-outgrowth inhibition and 100% PNMT induction), as 
defined in Materials and Methods. 
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Table II. 
Effects of synthetic and naturally occuring steroids 
on process-outgrowth and PNMT expression 
in SA progenitor cells in culture 
Steroid % inhibtion 
of process-outgrowth' 
A. Synthetic agonists and antagonists 
Dexamethesone, IJ.!M 100 
Dex, 100 nM' + 5 J.!M RU28318 
(type I GR antagonist) 101 ±3 
RU26988, 50nM 
(type-II GR agonist) 97 + 2 
R5020, 1 J.!M 
(PR agonist) 12± 1 
B. Endogenous steroids (all 1J.!M) 
Corticosterone 89±3 
II-deoxycorticosterone 79 ± 10 
Progesterone 61 ±3 
j3-estradiol 0±3 
Testosterone 4±4 

























*ND = not detectable 
'relative to IJ.!M DEX, as defined in Materials and Methods. 
bD separate determinations from (p) independent platings. 
'process outgrowth inhibition and PNMT induction in the presence of 
100nM Dex (alone) was indistinguishable from that seen in IJ.!M Dex; see 
Materials and Methods; d. Fig. 7B. 
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Figure 1. Antigen expression in freshly-isolated E14.5 SA progenitor cells. 
A. E14.5 HNK-1+ SA progenitor cells, isolated, plated and fixed as described 
in Materials and Methods. B. Same field as in (A), labelled with SA-1 
monoclonal antibody as described in Materials and Methods. C. E14.5 HNK-
1+ cells isolated, plated and fixed as in (A), stained for TH immunoreactivity 
as described in Materials and Methods. D. Same field as in (C), stained for 
PNMT immunoreactivity as described in Materials and Methods. A,B,C,D 
are matched exposures. Cells in A,B and C,D were plated, fixed and stained 
in parallel in the same experiment. Other experiments indicated that 
virtually all HNK-1+ cells were TH+, and that >70% of HNK-1+ cells were 





Figure 2. PNMT expression in vitro (qualitative). 
E14.5 HNK-l+ cells were cultured in the continued presence of either l~M 
CORT (A,B,C,D) or l~M DEX (E,F,G,H) for either 1 day (A,B,E,F) or 3 days 
(C,D,G,H), and assayed for both PNMT expression (A,C,E,G; matched 
exposures) and TH expression (B,D,F,H; matched exposures) by double-label 
immunofluorescence, as described in Materials and Methods. 
(A,B);(C,D);(E,F);(G,H) are paired exposures of identical fields. All conditions 
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Figure 3. PNMT expression in vitro (quantitative). 
E14.5 HNK-l+ SA progenitor cells were cultured in the continued presence 
of either 111M CORT (A) or 111M DEX (B) for 1 (E14.5+1) or 3 (E14.5+3) days, at 
which times they were assayed for TH and PNMT expression by double-label 
immunofluorescence, as described in Materials and Methods. Values are 
expressed as the %TH+ cells that are PNMT+. Each bar represents the mean 
+ S.E.M. for D separate determinations from (p) independent platings: CORT 























Figure 4. E14.5 SA progenitor cells after 3 days in culture (14.5+3). 
E14.5 HNK-1+ SA progenitor cells were cultured in the absence (A,B,C) or 
presence (D,E,F) of 11lM dexamathesone (DEX) for 3 days (until E14.5+3), at 
which time they were fixed and stained for TH (B,E) and PNMT (C,F) 
immunoreactivity by double-label immunofluorescence, as described in 
Materials and Methods. A,B,C and D,E,F are sets of photographs of identical 
fields from conditions plated in the same experiment. A,D are phase-
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Figure 5. Early inhibition of process-outgrowth by ce. 
E14.5 HNK-1+ SA progenitor cells were cultured in the absence (a,NO ADD) 
or presence of l~M CORT (b,CORT) or l~M DEX (c,DEX) for 15 hours, and 
fixed as described in Materials and Methods. When steroid was absent from 
the culture, many of the cell clusters extended processes (arrows), whereas in 
the presence of either CORT or DEX, the majority of cell clusters did not. 
Scale bar = 100~. d. Quantitation of process-outgrowth from E14.5 SA 
progenitors in the presence and absence of GC during the first 24 hours of 
culture. Cells as in (a-c) were cultured for 24 hours in the absence of steroid 
or in the continued presence of either l~M CORT or l~M DEX for 24 hours 
(until E14.5+ 1). The percentage of cell clusters bearing processes was 
determined for each indicated condition according to the criteria described in 
Materials and Methods. Each bar represents the mean + S.E.M. for 9-13 
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Figure 6. Serial Obseroations of Identified Cells. 
Upper: E14.5 HNK-1+ SA progenitors were plated at low density on gridded 
dishes as described in Materials and Methods. Individual cells were 
identified and photographed at 4 hours post-plating, and subsequently 
thereafter following a total of 24 and 48 hours in culture. A: representative 
cell cultured in the absence of steroid throughout the culture period. B: 
representative cell identified at 4 hours post-plating and subsequently 
cultured in the continued presence of l~M DEX. C: representative cell 
bearing processes at 4 hours post-plating and subsequently grown in the 
continued presence of l~M DEX. Cells bearing processes comprised <10% of 
the HNK-1+ population observed at 4 hours post-plating. Lower: Cell 
histories of identified cells. E14.5 HNK-1 + SA progenitor cells were isolated, 
plated and identified as described in Upper. Only cells which displayed a 
round morphology at 4 hours post-plating were included in the quantitative 
analysis shown here. After a total of 24 (DAY 1) and 48 (DAY 2) hours in 
culture in the absence of steroid (left side) or in the continued presence of 
l~M DEX (right side), each identified cell was scored as round, process-
bearing or dead. A total of 56 cells were tracked in the absence of DEX; 62 cells 
were tracked in its presence. The values listed represent the percentage of 
initially identified cells with each of the following histories: extended 
processes and survived; extended processes and died; remained round and 


































































































Figure 7. Dose-response curves for CORT- and DEX-induced process-
outgrowth inhibition and PNMT induction in the absence or presence of 
RU38486. 
A. E14.5 HNK-1+ SA progenitors were cultured in the continued presence of 
different concentrations of CORT ranging from 1nM to lOIlM, for 3 days. At 
E14.5+3, cultures were assayed for process-outgrowth (open symbols) and 
PNMT expression (filled symbols), as described in Materials and Methods. 
Values are presented as the percent of maximal activity, relative to 111M 
DEX, as defined in Materials and Methods. Each point shown represents the 
mean + S.E.M. from 4-7 separate determinations from 2-3 independent 
platings. 
B. Cells as in (A) were cultured in the continued presence of different 
concentrations of DEX, ranging from lOpM to 111M, for 3 days, and assayed 
for process-outgrowth inhibition (open symbols) and PNMT induction 
(filled symbols) at E14.5+3. Values are expressed as in (A). Each point 
represents the mean + S.E.M. of 4-6 separate determinations from 2-4 
independent platings. 
C. Cells as in (A) were cultured in the continued presence of lOOnM DEX, 
plus increasing concentrations of the type-II GC receptor antagonist RU38486 
ranging from 10nM to lOIlM, for 3 days. At E14.5+3, cultures were assayed for 
process-outgrowth inhibition (open symbols) and PNMT expression (filled 
symbols). Values are expressed as in (A). Each point represents the mean + 
S.E.M. of 4 separate determinations from two independent platings. 
D. Cells as in (A) were cultured in the continued presence of different 
concentrations of RU38486 ranging from 10nM to lO~M (open squares), or in 
the continued presence of 10nM DEX, plus increasing concentrations of 
RU38486 (filled diamonds), for 3 days. Cultures were assayed for process-
outgrowth inhibition at E14.5+3. Values are expressed as in (A). PNMT 
expression was undetectable in cells cultured in the continued presence of 
all concentrations of RU38486 (alone) examined. Each point represents the 
mean ± S.E.M. of 4 separate determinations from two independent platings. 
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Figure 8. Progesterone inhibits process-outgrowth from E14.5 SA 
progenitors, but does not induce PNMT expression. 
E14.5 HNK-1+ SA progenitors were cultured in the absence of steroid (A,B; 
same field) or in the continued presence of l~M progesterone (C,D; same 
field) for 3 days. At E14.5+3, cells were fixed and stained for both TH (A,C; 
matched exposures) and PNMT (B,D; matched exposures) expression by 
double-label immunofluorescence, as described in Materials and Methods. 
The exposures of TH and PNMT immunoreactivity shown here are 









Figure 9. PNMT expression after a 24-hour exposure to CORT given at two 
different times in culture. 
E14.5 HNK-1+ SA progenitor cells were cultured under the conditions listed 
below, and assayed for both PNMT (A,C,E,G; matched exposures) and TH 
(B,D,F,H; matched exposures), by double-label immunofluorescence, as 
described in Materials and Methods. A,B: in the continued presence of 1JlM 
CORT for 24 hours, and photographed at E14.5+1. C,D: in the absence of 
steroid for 2 days (until E14.5+2, at which time PNMT expression was 
undetectable; data not shown), followed by a 24 hour exposure to 1JlM 
CORT, photographed at E14.5+3. Note that the majority of cells within 
round clusters (arrows) are PNMT+. E,F: in the continued presence of 
progesterone for 2 days (until E14.5+2, at which time PNMT was 
undetectable; data not shown), followed by a 24 hour exposure to CORT in 
the absence of progesterone, photographed at E14.5+3. G,H: in the continued 
presence of WM CORT for 3 days, and photographed at E14.5+3. All 
conditions shown were plated, assayed and photographed in parallel in the 
















Figure 10. Quantitation of PNMT expression and process-outgrowth 
inhibition after a 24 hour exposure to CORT at two different times in 
culture. 
A. E14.5 HNK-1+ SA progenitor cells were cultured under the conditions 
described below, and assayed for PNMT expression as described in Materials 
and Methods. 24C: in the continued presence of 111M CaRT for 24 hours. 
48N /24C: in the absence of steroid for 48 hours, followed by a 24 hour 
exposure to 111M caRT. 48P /24C: in the continued presence of 111M 
progesterone for 48 hours, followed by a 24 hour exposure to 111M CaRT, in 
the absence of progesterone. 72C: in the continued presence of 111M CaRT 
for 72 hours. The data shown are from one representative experiment in 
which all conditions were plated in triplicate and assayed in parallel. Each 
bar represents the mean ± S.E.M. of the triplicate determinations. 
B. The identical conditions described in (A) were assayed for the percent of 
cell clusters displaying a round morphology. Each bar represents the mean + 
S.E.M. of the triplicate determinations. 
C. >100 cell clusters displaying a round morphology and containing a total of 
>300 cells were selected at random from among the triplicate wells plated in 
each of the conditions described in (A). The percent of cells within these 
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Figure 11. MODEL: Glucocorticoids control two sequential steps in 
chromaffin cell differentiation. 
Bipotential SA progenitor cells (expressing both neuron- and chromaffin-
specific genes) that migrate to the adrenal anlage are exposed to GC, which 
inhibit these cells from differentiating into neurons. In doing so, GC are 
permissive for the acquisition of competence to express PNMT upon a 
continued exposure to steroid. Thus, early exposure to GC is a prerequisite 
for the subsequent induction of epinephrine synthesis. By contrast, 
progenitor cells that migrate to the sympathetic ganglia primordia undergo a 
program of neuronal differentiation, which blocks the acquistion of 
competence, thus precluding the expression of PNMT. 
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TIME COURSE OF PNMT APPEARANCE IN VIVO 
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RESULTS 
The initial objective of the experiments described in Chapter 2 was to 
investigate the timing of PNMT expression in vitro, using a quantitative 
single-cell assay. As a standard for comparison, we first determined the 
schedule of PNMT appearance in vivo using a similar single-cell assay. 
Dissociated cell suspensions of purified chromaffin cells or their precursors 
from rat embryos of different ages were isolated as described in Materials and 
Methods (below), and the percentage of TH+ cells that expressed PNMT at 
each age was determined by double-label immunofluorescence. As shown in 
Figure 1, the onset of PNMT expression in vivo is well-defined. At E14.5 and 
EI5.5, detectable PNMT is present in fewer than 1 % of isolated cells. By E16.5, 
approximately 30% of the TH+ adrenal cells are PNMT-positive. One day 
later, at £17.5, PNMT appears in the majority of cells (70%). By EI8.5, the 
percentage of PNMT+ cells (81%) approaches the maximum values 
previously reported for mature populations of postnatal chromaffin cells 
(Doupe et aI., 1985a). Our results confirm at the single-cell level previous 
data documenting the developmental appearance of PNMT 
immunoreactivity in histological sections (Bohn et aI., 1981) and mRNA 
(Anderson and Michelsohn, 1989) (Appendix 11). [n.b. for references, see 
bibliography for Chapter 2.] 
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MATERIALS AND METHODS 
SA progenitor cells were isolated from rat embryos from between 14.5 and 
18.5 (E14.5-E18.5) days of age by fluorescence-activated cell sorting using 
monoclonal antibody HNK-l, as described in Chapter 2. Sorted, dissociated 
suspensions of cells were plated at a density of approximately 400 cells/mm2 
within cloning rings onto 24-well tissue culture plates that were previously 
coated with O.5mg/ml ploy-D-lysine. Cells were allowed to settle onto the 
substrate for approximately 20 minutes, after which time they were fixed" 
double-stained with anti-TH and PNMT antibodies, and assayed for the 
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Figure 1. PNMT expression in vivo. 
Purified HNK-l+ cells were isolated, allowed to adhere briefly to tissue-
culture wells, fixed, and then stained for TH and PNMT immunoreactivity, 
as described in Materials and Methods. Values are expressed as %TH+ cells 
that are PNMT+. Each point represents the mean + S.E.M. for D separate 
determinations from (p) independent platings: E14.5: 13(6); EI5.5: 15(5); E16.5: 
8(3); EI7.5: 8(3); EI8.5: 5(2). 
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ABSTRACT 
Chromaffin cells and sympathetic neurons develop 
from a common, neural crest-derived progenitor cell. The 
developmental fate of this cell differs depending upon 
whether it migrates to the sympathetic ganglion or to the 
adrenal gland primordium, suggesting that local 
environmental signals control Its differentiation. 
Glucocorticoid (GC) Is a good candidate for an important 
adrenal environmental signal. These steroids are known to 
regulate PNMT, an adrenal-specific enzyme. However, in 
vivo observations suggest that the adrenal 
microenvironment Influences the phenotype of 
sympathoadrenal progenitor cells as early as E14.5, two 
days before PNMT Is first expressed by developing 
chromaffin cells. Using cDNA probes, we find that GC 
receptor mRNA can be detected in the embryonic adrenal at 
least one full day before the initial appearance of PNMT 
mRNA. This observation is compatible with the idea that 
the apparent early influence of the adrenal 
microenvironment reflects the action of GC on progenitors 
which have migrated into this environment. In support of 
this, we show that similar influences can be exerted by GC 
on PC12 cells, which contain GCR mRNA but do not express 
or induce PNMT mRNA. Taken together, these data suggest 
that other factors in addition to the presence of the GCR 




Neural crest cells give rise to a wide array of differentiated 
derivatives following their migration from the top of the neural 
tube. The development of this heterogeneous cell population raises 
the question of the relative contributions of cell lineage and 
environmental determinants to its differentiation (LeDouarin, 1986). 
Among the derivatives of the neural crest are the endocrine 
chromaffin cells of the adrenal medulla, and the principal 
sympathetic neurons of the paravertebral autonomic ganglia. We 
have focused on the differentiation of these cells from the so-called 
sympathoadrenal lineage (Landis and Patterson, 1981) as a model 
system for addressing general questions of neural crest development 
and plasticity. 
It has clearly been shown that chromaffin cells and 
sympathetic nGlJrons develop from a common determined progenitor 
cell in vitro (Doupe et ai, 1985b; Anderson and Axel, 1986; Carnahan 
and Patterson, 1988.) In vivo, this progenitor can first be detected 
on E11.5 in the sympathetic ganglion primordia of the rat, by 
expression of tyrosine hydroxylase (Cochard et ai, 1979) and other, 
more recently-developed markers (Anderson, Carnahan and 
Patterson, unpublished.) Subsequently, some of these progenitors 
continue their migration ventrally to invade the adrenal anlagen, 
where they develop into chromaffin cells (Bohn et ai, 1981 ; 
Teitelman et ai, 1982) (Figure 1.) Others remain in the ganglion 
primordia, where they develop into sympathetic neurons. This 
behavior suggests that local environmental signals in the ganglion 
and the adrenal gland may control the choice of differentiation 
pathways by this bipotential progenitor cell. 
One environmental factor likely to be of importance in 
controlling chromaffin development is glucocorticoid (GC). Unsicker 
et al (1978) first showed that dexamethasone (dex), a synthetic 
glucocorticoid, could impair the NGF-induction of neurite outgrowth 
from neonatal chromaffin cells in vitro. It was suggested from this 
result and others (Unsicker et ai, 1985) that the presumably high 
local concentration of glucocorticoids in the adrenal gland (produced 
by the cortex) were important for maintaining the chromaffin 
phenotype. Subsequently, it was shown that glucocorticoids also 
function as a survival factor for neonatal chromaffin cells (Doupe et 
ai, 1985a). A role for glucocorticoid in the embryonic development 
of chromaffin cells was suggested by in vitro experiments showing 
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that sympathoadrenal progenitor cells from E14.5 fetal rat adrenal 
glands would invariably develop into sympathetic neurons unless 
supplied with exogenous GC (Anderson and Axel. 1986). In these 
experiments. the effect of GC on E14.5 progenitor cells was not 
measured until 4 days following their initial exposure to the 
steroid ; thus. it was formally possible that responsiveness to 
steroid was actually initially acquired during the 4-day culture 
period . Nevertheless. this finding was interpreted as being 
consistent with the idea that the migration of progenitor cells into 
the adrenal primordium at E13.5-E14.5 would expose them to a high 
concentration of steroid. which would then inhibit .the cell from 
differentiating along the neuronal pathway and promote its 
differentiation along the endocrine pathway (Figure 2). 
Glucocorticoid also acts to increase the expression of 
phenylethanolamine-N-methyltransferase (PNMT). the rate-limiting 
enzyme in epinephrine biosynthesis which is expressed by 
chromaffin cells but not by sympathetic neurons (Wurtman and 
Axelrod. 1966. Bohn et al. 1982; Grothe et al. 1985). The expression 
of PNMT during embryonic adrenal development first occurs between 
. E16.5 and E17.5. several days after progenitor cells have first 
invaded the adrenal primordium (Bohn et al. 1981; Teitelman et al . 
1982.) This phenomenon raises the question of what factors are 
responsible for the delay in the expression of this gene. As the 
appearance of PNMT correlates temporally with a sharp rise in 
corticosterone synthesis by the adrenal cortex. and as PNMT is a GC-
inducible enzyme. a logical explanation initially was that the time 
.of appearance of PNMT was controlled by the time of appearance of 
its inducer. Such an explanation. however. would be at odds with the 
suggestion that GC exerts an important influence several days 
earlier in development (E14.5). when it would act to inhibit the 
neuronal differentiation of progenitor cells. Indeed. measurements 
by Roos (1967) showed that steroidogenesis by the embryonic 
adrenal could be detected as early as E12.5 in the rat. 
One resolution to this apparent paradox was suggested by 
experiments which indicated that the initial appearance of PNMT 
occurred on schedule whether or not corticosteroids were removed. 
or added prematurely. implying that induction of this gene is 
independent of the presence of steroids (Bohn et al. 1981; Teitelman 
et al. 1982.) However. these experiments were performed in vivo 
and in organ culture. under conditions where it was impossible to 
prove the unequivocal elimination of all endogenous sources of 
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steroid. Nevertheless, more recent experiments have indicated that 
PNMT appears on schedule in cultures of purified E14.S adrenal 
progenitors, despite the presence of micromolar dex from the time 
of plating (Michelsohn, A. and Anderson, D.J., unpublished), in 
ag reement with earlier in vivo studies (Boh n et ai, 1981). 
Therefore, the time of PNMT appearance is clearly not controlled by 
the time of appearance of its inducer (GC). However, more recent 
experiments (see Seidl et. aI., 1988 and this volume) have suggested 
that the appearance of detectable PNMT in vitro nonetheless requires 
the presence of GC. 
The apparent dependence of correctly-timed PNMT expression 
upon the presence of inducer suggests another explanation for the . 
delay in PNMT appearance: a delay in the appearance of the receptor 
for the inducer, i.e., the GC receptor (GCR). Indeed, Seidl et. al. (this 
volume) preseDt convincing data that functional GCR cannot be 
detected in purified chromaffin precursors until E17.S, the time at 
which PNMT first appears. If this explanation were valid, it would 
imply that the progenitor cells which migrate into the adrenal gland 
at E14.S are initially unresponsive to steroid. In this paper, 
however, we present evidence that E14.S progenitors in the adrenal 
gland primordium already are phenotypically distinct from their 
ganglionic counterparts at this early age. Specifically, they appear 
to be inhibited from undergoing neuronal differentiation, implying an 
early effect of the adrenal microenvironment. Moreover, such an 
inhibition can be mimicked, at least in part, by GC on a 
sympathoadrenal lineage-derived cell line (PC12) (Greene and 
Tischler, 1976) which neither expresses nor induces PNMT mRNA in 
response to the steroid. Taken together, these data are consistent 
with the idea that progenitors could be responsive to GC prior to 
their expression of PNMT. In support of this, GC receptor (GCR) 
mRNA appears in the embryonic adrenal at least one full day before 
the appearance of PNMT mRNA. These data imply that GC exert an 
early influence on chromaffin cell differentiation, and therefore 
that factors other than the appearance of the GCR must be 
responsible for the delay in the initial activation of the PNMT gene. 
MATERIALS AND METHODS 
A full-length bovine PNMT cDNA probe (Batter et ai, 1988) was 
used to screen an adult rat adrenal medulla Agt10 cDNA library 
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(Anderson and Axel, 1985). Approximately 50,000 clones were 
screened at high stringency. Positives were picked, the phage grown 
up and insert DNA isolated by restriction with EcoRI. These isolated 
inserts in turn were radio labeled and used to probe Northern blots of 
adrenal medullary RNA to confirm the identity of the clone (see 
Figure 5). RNA isolation, Northern blotting and hybridization with 
single-stranded cRNA probes prepared by SP6 in vitro transcription 
were all performed as described previously (Anderson and Axel, 
1985). For the developmental Northern blot series, embryos were 
designated as 0.5 days of gestation the morning a plug was detected 
following a midnight breeding. Fluorescence-activated cell sorting 
and immunohistochemical techniques were carried out as detailed 
elsewhere (Anderson and Axel, 1986; Stein et ai, 1988b). 
RESULTS 
Sympathoadrenal progenitors in the E14.5 adrenal gland are 
antigenically-distinct from their ganglionic counterparts. 
In an earlier study, we identified a monoclonal antibody, called 
82, which transiently labels developing neurons in the sympathetic 
ganglion (Figure 3C, arrowhead.). Although this cell-surface marker 
is expressed by a subset of cells within the adrenal gland (Anderson 
and Axel, 1986), it is absent from the majority of TH-positive cells 
in the gland in the same histological section (Figure 3A, small 
arrow; compare with C). That 82+ cells are advanced in neuronal 
differentiation is indicated by the appearance of these cells 
immediately following their isolating by sorting : these cells exhibit 
a strikingly more neuronal morphology (Figure 4C,D) than their 82-
adrenal counterparts (Figure 4A,8.) Similarly, progenitor cells 
which migrate into the adrenal gland at E14.S extinguish expression 
of SCG10 (Figure 38), a neural-abundant vesicle protein (Stein et ai, 
1988b) which is first expressed at E11.S; in contrast cells which 
remain in the ganglion sustain and up-regulate SCG10 expression 
(Figure 38, arrowhead.) These data imply that progenitors which 
migrate into the adrenal gland are inhibited from undergoing 
neuronal differentiation. More recent data indicate that in addition 
to this apparent inhibitory influence of the adrenal 
microenvironment, this environment maintains the expression of 
some newly-defined chromaffin-specific antigens , which initially 
appear in progenitors at E11.S but which are lost by ganglionic cells 
beginning on E13.5 - E14.5 (Anderson, Carnahan and Patterson, 
unpublished observations.) In vitro, the persistence of these 
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antigens depends upon the presence of dex (Carnahan and Patterson, 
personal communication.) 
Taken together, these more recent data suggest that 
developing chromaffin cells become phenotypically distinct from 
developing sympathetic neurons at least two to three days before 
the initial appearance of PNMT. The ability of synthetic GC to 
promote these phenotypic distinctions in vitro in progenitor cells 
which do not yet express PNMT (Anderson and Axel, 1986; Carnahan 
and Patterson, personal communication) suggests that GC are the 
adrenal environmental determinant responsible for these early 
differences. To begin to examine this issue at the molecular level, 
we have cloned a rat PNMT cDNA and used it to study the relationship 
between expression of PNMT mRNA and that of the GC receptor 
mRNA. 
Isolation of a rat PNMT eDNA 
We cloned a rat PNMT cDNA by screening an adult adrenal 
medulla cDNA library (Anderson and Axel, 1985) with a bovine PNMT 
cDNA probe (Batter et. aI., 1987). Hybridization of this rat cDNA 
. probe to total adult adrenal medulla RNA revealed an intense band of 
approximately 1100 nucleotides (Figure 5B). An identically-sized 
band was revealed using the bovine probe (Figure SA), confirming the 
identity of the rat clone. However, the intensity of the hybridization 
Signal obtained using the rat probe appeared more than ten-fold 
greater than that seen with the bovine probe, reflecting species 
divergence in the nucleotide sequence of the rat and bovine genes (B . 
. Kaplan, personal communication). The size of the rat PNMT cDNA is 
about 800 bp, indicating that it is not full-length. Nevertheless, it 
is useful as a hybridization probe to detect specific expression of 
this gene. 
PC12 cells respond to GC, but neither express nor induce PNMT.mRNA 
In order to determine whether PC12 cells would be a useful 
model system in which to study the regulation of PNMT gene 
expression, we performed Northern blot analysis of RNA obtained 
from this cell line in the presence and absence of 5 JlM dex. This 
experiment revealed that PC12 cells do not detectably express PNMT 
mRNA (Figure 5, lanes PC12-). We estimate that the sensitivity of 
our Northern hybridization procedure, using high-specific activity 
single stranded cRNA probes, is sufficient to permit the detection of 
PNMT mRNA at an abundance of 1 copy per cell. Moreover, PC12 cells 
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did not induce PNMT mRNA upon exposure to GC (Figure 5, PC12+) for 
several days. However, PC12 cells contain GCRs and respond in other 
ways to GC: they increase expression of TH mRNA (Figure 6B)(Lewis 
et ai, 1983; Leonard et ai, 1987), and show a decreased magnitude of 
SCG10 mRNA induction by NGF (Figure 6A). Leonard et. al. (1987) 
also identified several other genes which are induced by GC in PC12 
cells, as well as several genes whose NGF-induction in these cells is 
inhibited by GC. Thus, PC12 cells display both positive and negative 
responses to GC, but neither express nor induce PNMT mRNA. 
Expression of GCR mRNA precedes that of PNMT mRNA during adrenal 
development 
We next examined the expression of PNMT mRNA at various 
stages of development. Total RNA isolated from whole embryonic 
adrenal glands was analyzed by Northern blotting using a PNMT cRNA 
probe. In agreement with previously published immunohistochemical 
data (Bohn et ai, 1981; Teitelman et ai, 1982), we found that PNMT 
mRNA was undetectable at E15.5, but was clearly expressed one day 
later, at E16.5 (Figure 7, PNMT). However, TH mRNA was present at 
. E15.5 and its amount did not change between E15.5 and E16.5 (Figure 
7, TH), indicating that the absence of PNMT mRNA at E15.5 was not 
due simply to the absence of sympathoadrenal lineage cells in the 
tissue used to prepare RNA. Unfortunately, the small quantities of 
material available at E14.5 precluded a measurement of PNMT mRNA 
at this early age. Note that the ratio of PNMT to TH mRNA appears to 
increase between E15.5 and birth, implying a selective induction of 
. this gene rather than simply proliferation of the PNMT+ cell 
population . 
The availability of a cloned probe for the GCR (Miesfeld et ai, 
1984) next permitted us to examine the appearance of the receptor 
mRNA in relationship to that of the PNMT mRNA. The same Northern 
blot was stripped and rehybridized with a GCR cRNA probe. This 
experiment revealed the characteristic 7 kb GCR mRNA at all stages 
of development examined (Figure 7, GCR). However, this band is less 
readily apparent in the E15.5 sample because the slight RNA 
degradation in this sample (Figure 7, ACTIN) affects a large mRNA to 
a greater extent than a smaller one; nevertheless, the presence of 
RNA hybridizing to the GCR probe in this lane is clear. Therefore, at 
least some GCR mRNA is present in the embryonic adrenal gland fully 
one day prior to the appearance of PNMT mRNA. 
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The apparent degradation of the E15.5 mRNA sample precludes 
a quantitative comparison of. GCR mRNA levels in the adrenal 
betweenE15.5 and E1S.5; it is possible that some up-regulation of 
the transcript occurs over this developmental interval when PNMT 
mRNA is being induced. However, in support of the idea that PNMT 
expression does not necessarily reflect increased GCR mRNA 
expression, we observed that there was no large difference in the 
amount of GCR mRNA between the adrenal medulla and neonatal 
superior cervical sympathetic ganglion (Figure 7C, SCG), although 
PNMT mRNA did not appear to be expressed in the ganglion (Figure 
7A), consistent with previous immunohistochemical studies (Bohn et 
ai, 1982.) Because NGF inhibits the ability of GC to induce TH mRNA 
in PC12 cells (Figure SB; see also Leonard et ai, 1987), it was of 
interest to determine whether this inhibition was due to a 
depression of GCR mRNA levels. Northern hybridization revealed, 
however, no significant difference in the levels of GCR mRNA 
between untreated and NGF-treated PC12 cells (Figure 7, lanes 
PC12- and PC12+.) 
DISCUSSION 
In an effort to determine whether the timing of PNMT 
expression is likely to be controlled by the time of appearance of the 
GCR in developing chromaffin cells, we have examined the relative 
time of appearance of the mRNAs for these two proteins using 
. cloned probes. Our data indicate that GCR mRNA is qualitatively 
detectable in the embryonic adrenal gland at E15.5, one full day prior 
to the appearance of PNMT mRNA. Moreover, our results show clearly 
that progenitor-like sympathoadrenal lineage cells (represented by 
the PC12 line) can express GCR mRNA and respond in several ways to 
GC, without either expressing or inducing PNMT mRNA. A similar 
result was obtained in the sympathetic ganglia. Taken together, 
these and other data (cf. Figure 3) appear consistent with the 
hypothesis that embryonic sympathoadrenal progenitors contain GCR 
and respond to GC several days prior to the appearance of PNMT, and 
therefore imply that other factors in addition to the presence of GCR 
may be necessary for the developmental appearance of PNMT 
expression. For example, expression of the gene could require the 
appearance of a temporally-regulated trans-activator protein, or a 
change in chromatin structure. Such mechanisms have been 
suggested to underly the selective regulation of tissue-specific 
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genes by steroid hormones in other systems (Burch and Weintraub, 
1983.) 
The conclusions drawn above must, however, be tempered by 
several important caveats at the present time. First, the mere 
expression of GCR mRNA does not mean that a functionally active 
GCR is necessarily present. Second, as the RNA samples analyzed 
were from whole adrenal glands and not from purified progenitor 
cells, it is possible that the GCR mRNA detected was contributed by 
other cells in the gland (eg, cortical cells). (However, the specific 
activity of the GCR mRNA is virtually identical in adult medulla and 
embryonic whole adrenal glands (as well as in SCG and PC12 cells), 
suggesting that most if not all cells in the samples analyzed express 
GCR mRNA.) Third, the demonstration that the presence of 
functiona~ GCRs in PC12 is not sufficient for expression of PNMT 
logically does not exclude the possibility that such receptors may 
nevertheless be necessary for PNMT expression. These caveats 
could account for the difference between the results reported here 
and the findings of Seidl et al (this VOlume), who measured no GCR in 
purified E16.5 chromaffin precursors using a radio ligand binding 
assay, and who showed a dramatic induction of receptors over the 
next few days. 
If, in fact, there are no functional GCRs in chromaffin cells 
prior to E17.5, other models must be advanced to account for the 
apparent effects of the adrenal microenvironment on 
sympathoadrenal progenitor phenotype at E14.5 (Figure 3). One 
possibility is that prior to E 17.5, the main effect of the adrenal 
microenvironment is to exclude inducers of neuronal differentiation 
which may be located in the sympathetic ganglion primordia (eg., see 
Stemple et ai, 1988.) The suppression of neuronal differentiation 
observed within the adrenal at this early stage would in that case 
result from the absence of a neural inducer, rather than the presence 
of an inhibitor (GG). This model would be compatible with an initial 
unresponsiveness of E14.5 progenitors to GC. A second possibility is 
that adrenal corticosteroids do suppress the neuronal 
differentiation of progenitors at E14.5, but that the effect of GC is 
mediated indirectly, through some other cell type present in the 
adrenal. This model would be consistent with our finding of GCR 
mRNA in the adrenal prior to E17.5. Neither of these two models, 
then, require that GCRs appear in developing chromaffin cells until 
E17.5, as suggested by the data of Seidl et al. 
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Another model that could reconcile our data with those of 
Seidl et al is one in which PNMT induction does not occur until a 
threshhold concentration of GCR is reached, but that levels of . GCR 
below this threshhold are still sufficient to mediate the earlier 
apparent effects of steroids on progenitor cells. Studies of other 
steroid-inducible genes are consistent with the idea that different 
genes within the same cell may require different levels of steroid 
receptor to be induced, perhaps due to intrinsic differences in the 
affinities of these genes for the steroid-receptor complex (Barton 
and Shapiro, 1988.) In this respect, it is of interest that the bovine 
PNMT gene contains five consensus Glucocorticoid-Responsive 
Elements (GREs) (Batter, et. aI., 1988); perhaps all of these sites 
must be occupied by the hormone-receptor complex in order for 
expression of the gene to occur. The observation of Seidl et. a!. that 
the rise In functional GCR occurs during the same period in which 
corticosterone synthesis is rising is, furthermore, consistent with 
the idea that the steroid may induce its own receptor. The delay in 
PNMT appearance could, then, reflect the time required for GCR 
levels to be induced above a threshhold level necessary for 
activation of PNMT transcription. Our present data do not rule out a 
rise in GCR mRNA levels during adrenal development. It is also 
possible that the rise in steroid-binding activity observed by Seidl 
et al occurs by a post-transcriptional activation of the receptor. 
Precedent for an autoinduction of steroid receptors exists in other 
systems (Barton and Shapiro, 1988.). A self-reinforcing action of GC 
on chromaffin differentiation would account for other features of 
the chromaffin-neuron developmental decision, as discussed 
elsewhere (Anderson, 1989). 
Thus, the data presented here unfortunately do not settle the 
issue, but (especially when taken together with the results of Seidl 
et al) make it evident that the regulation of PNMT expression and 
chromaffin differentiation by GC are likely to be more complex than 
previously appreciated. However, our data clearly show that the 
presence of functional GCRs in a sympathoadrenal lineage-derived 
cell (the PC12 cell) is insufficient to achieve expression of the 
PNMT gene, and that nevertheless GC is able to exert effects on 
these cells similar to those observed on early progenitors (ie., 
suppression of neural-specific gene expression.) In fact, the early 
inhibition of neuronal differentiation in the developing chromaffin 
population could actually be required for subsequent expression of 
PNMT. This is because cells differentiating along the neuronal 
pathway apparently rapidly lose the ability to express PNMT in 
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response to GC (Bohn et. aI., 1982, Anderson and Axel, 1986; 
Anderson, 1988). Thus, the ability to express PNMT at E 16.5 may be 
the consequence of a cell lineage decision made several days earlier 
in development. Our data are consistent with the idea that GC is an 
important environmental determinant of this earlier decision. 
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Schematic indicating the migratory route taken by cells in the 
sympathoadrenal lineage. The diagram illustrates a section through 
an E14.S embryo. with earlier developmental events superimposed. 
(After Anderson. 1988.) 
Figure 2. 
A model for sympathoadrenal development. The diagram 
illustrates the changes in cellular morphologies and factor-
responsiveness thought to occur at different stages in the lineage. 
The cells labeled "primitive neuron" correspond to the B2+ cells (see 
Figure 4.) These cells are still mitotic. (From Anderson and Axel. 
1986) . -
Figure 3. 
Differential expression of neural-specific markers in the 
E14.S sympathetic ganglion and adrenal gland. (A) The overall 
distribution of sympathoadrenal progenitors in the adrenal gland and 
sympathetic ganglion (large arrowhead) is shown by TH staining. 
Medial is to the right. (B.C) nearby sections stained with either 
anti-SCG10 (B) or B2 (C). Only the region containing the sympathetic 
ganglion (large arrowhead) and medial portion of the adrenal gland is 
shown. and the magnification is twice as high as in (A). Note that 
while the ganglion (arrowhead) is strongly positive for both SCG10 
(B) and B2 (C). most of the cells within the adrenal gland are 
negative (compare to the region bounded on the left by the small 
arrow in (A». However. a few scattered SCG10+ cells can be seen. 
and there is a characteristic cluster of B2+.SCG10+ cells at the 
extreme medial margin of the adrenal (small arrows in (B) and (C) .) 
This region will later become the extra-adrenal ganglionic complex. 
Figure 4. 
Sympathoadrenal precursors at two different developmental stages 
can be isolated by fluorescence-activated cell-sorting with 
different antibodies. HNK-1 recognizes a carbohydrate epitope 
present on the surfaces of all TH+ cell types in the embryonic 
adrenal gland. but absent from cortical and mesenchymal cells . 82 
recognizes a surface carbohydrate epitope which at E14 .S is 
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expressed in the embryo exclusively by neuroblasts in the 
sympathetic ganglia. and by a subset of cells within the adrenal 
gland. Cells isolated using monoclonal antibody B2 (C.D) have 
extended long processes by 12-24 hrs after plating . Those isolated 
with HNK-1 (from the B2- fraction) are more fully bipotential (A.B). 
although with time many of these cells begin to extend processes as 
well (arrow. A) . The B2+ cells contain a subpopulation which is less 
mature and still responsive to dex (arrow. C). (After Anderson. 
1988.) 
Figure 5. 
Identification of a rat PNMT cDNA clone and analysis of PC12 
cells. Two identical Northern blots containing the RNA samples 
indicated (10 Jlg/lane) were hybridized and washed to high 
stringency with a bovine PNMT cDNA probe (A) or a newly-isolated 
rat PNMT cDNA probe (B). Note that the rat probe detects an 1100 
bp mRNA identical in size to that seen using the bovine probe. No 
detectable PNMT mRNA is seen in PC12 cells with or without 5 JlM 
dexamethasone using either probe. 
Figure 6. 
PC12 cells respond both negatively and positively to 
glucocorticoid . (A). dex inhibits the ability of NGF to induce the 
neural-specific SCG10 mRNA. (B) dex induces TH mRNA. (C) control 
using actin probe to show that equivalent amounts of mRNA were 
loaded in each lane. (D. E) quantitation of the results shown in (A) 
and (B). (F). dex inhibits the basal levels of SCG10 expression. 
independent of its ability to interfere with NGF induction. After 
Stein et al. 1988a. 
Figure 7. 
Expression of GCR mRNA precedes that of PNMT mRNA during 
embryonic adrenal gland development. 10 Jlg of total RNA from the 
indicated tissues at various developmental stages were analyzed by 
Northern blotting. The same blot was hybridized sequentially with 
the probes indicated to the right. E15.5 -E20.5 and P3 (postnatal day 
3) represent RNA isolated from whole adrenal glands; Ad. indicates 
RNA from adult adrenal medulla. PC12- and PC12+ indicate RNA 
from PC12 cells treated without or with 50 ng/ml NGF for 24 hrs. 
respectively. Note that while no PNMT mRNA is detectable at E15.5. 
TH mRNA is present at this stage. The ratio of TH mRNA to actin 
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mRNA is comparable between E15.5 and E17.5. during a period when 
PNMT mRNA is increasing. (C) Arrowhead indicates the 7 kb GCR 
mRNA; upper and lower arrows indicate the 285 and 185 rRNAs. 
respectively. Some degradation of the E15.5 RNA sample has 
occurred (see also D). accounting for the smear of hybridization 
signal obtained with the GCR probe. Nevertheless the 7 kb band can 
be detected in this lane. Note the presence of GCR and TH mRNAs in 
the P3 Superior Cervical Ganglion (P3). but the absence of PNMT 
mRNA. 
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antibody markers and double-label 
immunofluorescence microscopy, we have followed the fate of progenitor 
cells in the sympathoadrenal sublineage of the neural crest, in developing 
rat embryos. Such progenitors are first recognizable in the primordial 
sympathetic ganglia at embryonic day (E) 11.5, when they express 
tyrosine hydroxylase (TH). At this stage, the progenitors also co-express 
neuronal markers such as SCG10 and neurofilament, together with a 
series of chromaffin cell markers called SAl-5 (Carnahan and Patterson, 
1991a.) The observation of such doubly-labeled cells is consistent with 
the hypothesis that these cells represent a common progenitor to 
sympathetic neurons and adrenal chromaffin cells. Subsequent to El1.S, 
expression of the chromaffin markers is extinguished in the sympathetic 
ganglia, but retained by cells within the adrenal gland. Concomitant with 
the loss of the SA1-S immunoreactivity, a later sympathetic neuron· 
specific marker, 82, appears in sympathetic ganglia. In dissociated cell 
suspensions, some 82+ cells that co·express SAl are seen. This implies a 
switch in the antigenic phenotype of developing sympathetic neurons, 
rather than a replacement of one cell population by another. The SAl~82 
transition does not occur for the majority of cells within the adrenal 
primordium. In vitro, most B2+ cells fail to differentiate into chromaffin 
cells in response to glucocorticoid. Instead, they continue to extend 
neurites, and then die. Taken together, these data imply that the SAl" 82 
transition correlates with a loss of competence to respond to an inducer of 
chromaffin differentiation. Thus, the development of sympathoadrenal 
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derivatives is controlled both by environmental signals, and by changes in 
the ability of differentiating cells to respond to such signals. 
An important problem in developmental neurobiology concerns the mechanism of 
diversification of the cell types that derive from the neural crest. The dissection of this 
process has been aided by the use of monoclonal antibodies, which have proven useful 
tools for the study of neural development (Mirsky, 1982, Reichardt, 1984). Such 
antibodies can provide molecular markers of differentiation, and can reveal important 
differences between cells that are otherwise indistinguishable. The preceding paper 
(Carnahan and Patterson, 1991a) describes the generation and characterization of a novel 
set of monoclonal antibodies (SAI-5) that, in the postnatal rat, specifically label adrenal 
chromaffin cells, the major endocrine derivative of the neural crest. These antibodies 
provide a set of reagents that can be used to identify chromaffin cells and their precursors 
in developing embryos. 
Studies of postnatal (Doupe et aI., 1985a; Doupe et aI., 1985b; Unsicker et a!., 
1978) and of embryonic chromaffin cells (Anderson and Axel, 1986, Seidl and Unsicker, 
1989a, Seidl and Unsicker, 1989b) have suggested that these adrenal medullary cells 
derive from a progenitor whose alternate fate is to become a sympathetic neuron. 
However it has been difficult to establish whether this lineage relationship holds in vivo. 
To address this issue, we have examined in sections of developing rat embryos the pattern 
of expression of the chromaffin-specific SA antigens in relationship to that of neuron-
specific markers. Neuronal markers in this lineage include intracellular proteins such as 
neurofIlament 68 kD (Cochard and Paulin, 1984) and SCOlO (Anderson and Axel, 1985; 
Stein et a!., 1988b), as well as cell surface antigens such as B2 (Anderson, 1988, 
Anderson and Axel, 1986). Because several of these markers are sequentially expressed 
in an overlapping manner, the developmental segregation of sympathetic neurons and 
chromaffin cells from their precursor(s) can be traced in situ. 
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We find that SA1+ cells within the sympathetic ganglion primordium initially co-
express SCG 10 and ill, suggesting that they have the potential to become either 
sympathetic neurons or chromaffin cells. Subsequently, SAl immunoreactivity is lost 
and B2 immunoreactivity appears in these sympathetic neuroblasts. By contrast, this 
antigenic switch does not occur for most of the developing adrenal medullary population. 
Experiments in vitro suggest that the SAl .. B2 switch correlates with a loss of 
competence to respond to glucocorticoids, and commitment to the neuronal pathway of 
differentiation. 
MATERIALS AND METHODS 
Immunocytochemistrv 
Staged embryos were fixed in 4% paraformaldehyde, embedded and sectioned in 
a cryostat as described (Carnahan and Patterson, 1991a). Double-labeling was performed 
using an SAl ascites fluid diluted 1 :2000, together with: undiluted B2 hybridoma 
supernatant ·(a gift from J. Dodd, Columbia University); polyclonal rabbit anti-ill 
diluted 1 :250 (Eugene Tech Inc., NJ); or polyclonal rabbit anti-SCG 10 diluted 1 :250 
(Stein et al., 1988a.) Sections were incubated overnight at 4°C with primary antibody, in 
the presence of 1 % normal goat serum (NGS) and 0.1 % Nonidet P 40 (NP40). After 
thorough washing to remove unbound primary antibody, sections incubated with SAl 
plus anti-ill or SAl plus anti-SCG 10 were developed using Rhodamine Goat anti-rabbit 
IgG at 1:500 plus FITC Goat anti-Mouse IgG at 1:200 (TAGO, Inc., Burlingame, CAl. 
Sections incubated with SAl plus B2 were developed using Rhodamine Goat anti-Mouse 
IgM (TAGO) and FITC Goat anti-Mouse IgG (Southern Biotech, Inc., Atlanta, GA), 
both at 1: 100. To reduce nonspecific binding, dilutions of secondary antibody were pre-
cleared by incubating for 1 hr at 4°C in 10% normal rat serum, 5% NGS, and then 
centrifuged for 10 min. at 14,000 xg. Controls lacking primary antibody exhibited no 
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specific staining. Sections were mounted in para-phenylenediamine/glycerol and 
examined in an Olympus OMT-2 inverted microscope. All micrographs in this .paper 
illustrating SA 1 vs. B2 staining were photographed and printed using identical exposure 
times, so that staining intensity is directly comparable between the figures. For the 
detection of PNMT immunoreactivity, a rabbit anti-PNMT antiserum (the generous gift of 
Dr. Martha Bohn) was used at a dilution of 1:1000, and visualized using an FITC-
conjugated Goat anti-rabbit IgG secondary antibody (TAGO) at 1:200. 
Isolation and culture ofB2+ and B2- cells by FACS 
B2+ cells were isolated from dissociated suspensions of E14.5 adrenal glands by 
surface labeling and FACS as previously described (Anderson and Axel, 1986). B2- cells 
were isolated using monoclonal antibody HNK-l (Abo and Balch, 1981), which labels all 
TH+ cells within the E14.5 adrenal gland (Anderson and Axel, 1986; Birren and 
Anderson, 1990). We used HNK-l rather than the SA(I,2&4) cocktail (Carnahan and 
Patterson, 1991b) to isolate B2- progenitors, because the SA antigens are poorly 
expressed on the cell surface in E14.5 adrenal suspensions (1. Carnahan, unpublished 
observations). As all B2+ cells are also HNK-l+, however, in order to isolate the B2-
fraction, the B2+ cells first had to be eliminated by complement lysis using monoclonal 
antibody B2. The remaining B2- cells were then labeled with HNK-l ascites diluted 
1:500 and FlTC Goat anti-Mouse IgM (TAGO). Virtually all HNK-l+, B2- cells are TH+ 
and over 80% are SA1+, indicating that HNK-l (in combination with B2 elimination) is 
an sympathoadrenal lineage surface marker comparable to the SA antibodies, for the 
E14.5 adrenal gland. B2+ and HNK-l+ (B2-) cells were separated from unlabeled cells 
by FACS using an Ortho instrument (Ortho Diagnostics, Inc.) Approximately 1-2% of 
the input cells were B2+ while 6-7% were B2-, HNK-l+. Cells were cultured on a 
collagen/poly-D-lysine/larninin substratum in steroid-stripped LI5-C02 complete medium 
as previously described (Anderson and Axel, 1986), except that fetal calf serum was 
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substituted for rat serum. When included, dexamethasone was diluted from a stock 
solution of 10-3 Min 95% ethanol, to a final concentration of 1 11M. For quantifying the 
inhibition of process outgrowth, a cell cluster was defined as "process-bearing" if any 
cytoplasmic extension could be detected originating from the cluster. It was not possible 
to determine whether every cell in a cluster was process-bearing, because the tight 
clumping of the cells precluded assignment of processes to individual cells. Nonetheless, 
for the purposes of this study this measurement represents a highly stringent criterion, in 
that only clusters containing exclusively rounded cells were counted as non-process-
bearing. Any systematic error introduced by this method would, if anything, 
underestimate the difference in process outgrowth between B2- and B2+ cells. For 
single-cell tracking experiments, cells were identified 24 hrs after plating and their 
positions marked by means of a gridded coordinate system embossed in the bottom of the 
dish using a BB press. Cells were photographed at that time and every 24 hrs thereafter 
for the next 2 days. 
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RESJJLTS 
Transient co-expression of neuronal- and chromaffin-specific markers by 
cells in embryonic sympathetic ganglia 
In the postnatal rat, the SAI-5 series of monoclonal antibodies specifically labels 
adrenal chromaffin cells but not sympathetic neurons (Carnahan and Patterson, 1991a). 
In developing embryos, however, expression of the SAl antigen is detectable in cells of 
the primordial sympathetic ganglia, beginning at EI1.5 (Figure lA; see also Carnahan and 
Patterson, 1991 a). At this time, neural crest cells have just aggregated in clusters adjacent 
to the dorsal aorta, and can be recognized by their expression of tyrosine hydroxylase 
(TH), a lineage marker for adrenergic neural crest derivatives (Cochard et al., 1979). 
Double-labeling indicates that all SA1+ cells appear to co-express TH, and vice-versa 
(Fig. IB). No expression of SA 1 can be detected in premigratory or in migrating neural 
crest cells one day earlier in development (data not shown). 
The initial expression of SA 1 coincides not only with that of TH, but also with 
that of neural-specific markers such as SCG 10 (Anderson and Axel, 1985; Stein et aI., 
1988b) and neurofilament 68 Kd subunit (NF68) (Cochard and Paulin, 1984). To 
determine whether such neuronal markers are co-expressed in the same cells as express 
SAl, double-label immunohistochemistry was performed using a rabbit anti-SCGlO 
antibody (Stein et aI., 1988b), mouse monoclonal SAl antibody and species-specific 
secondary antibodies. Within the ganglionic cluster, SCG 10 (Figure ID) is expressed in 
an overall pattern that is co-extensive with that of SA 1 (Figure 1 C). At higher 
magnification (Figure 1, E,F), individual cells labeled by both anti-SCGlO and SAl are 
visible; many of these cells are process-bearing (lE,F; arrows). It is difficult to determine 
whether all SA1+ cells are also SCGlO+, however, because the SCGlO antigen is 
membrane bound (Stein et aI., 1988b) and concentrated in the perinuclear region (Figure 
ID, arrow) whereas the SA 1 antigen exhibits a punctate, cytoplasmic distribution (Fig. 
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IC,arrowhead). Nevertheless a substantial number of double-positive cells can be 
observed. For technical reasons, double-labeling with monoclonal SAl and NF68 
antibodies was not possible. However, the timing of 11f and NF68 appearance are 
coincident (Cochard et al., 1979; Cochard and Paulin, 1984), and 11f and NF68 are co-
expressed in sympathoadrenal precursors (Anderson and Axel, 1986). It is therefore 
likely that SAl + ganglionic cells co-express NF68 as well as SCQ 10. 
The co-expression of SA I, 11f and SCQ 10 in individual ganglionic cells persists 
through EI2.S (Figure 2A,B,C,D). After this time, the expression of SA I in the 
sympathetic ganglia begins to decline (see also Carnahan and Patterson, 1991a). 
However expression of SCQ 10, 11f and NF is maintained, as previously described 
(Anderson and Axel, 1986, Cochard et aI., 1979; Cochard and Paulin, 1984). 
Cells in sympathetic ganglia begin to express B2 coincident with the loss 
of SAl 
Previously, monoclonal antibody B2 (J. Dodd, unpublished) was shown to 
specifically label a population of neuronal precursors in EI4.S sympathetic ganglia, as 
well as a subset of cells within the adrenal gland (Anderson and Axel, 1986). As B2, like 
the SA antibodies, appears to be highly specific for cells of the sympathoadrenallineage, 
it was of interest to determine the relative timing of expression of these two markers. In 
contrast to SAl, no staining with B2 can be detected in sympathetic ganglia, or elsewhere 
in the embryo, at EIl.S (not shown). At EI2.S, faint patches of punctate B2 staining can 
occasionally be seen (Fig. 2F). These patches overlap some of the SA 1+ cells (Figure 
2E). Over the next few days of development (E13.S - EIS.S), the intensity of B2 
expression in the sympathetic ganglia increases, while that of SA I decreases (compare 
exposure-matched Figures 2F, 3B and 4B), until SAl expression appears completely 
replaced by that of B2. 
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The increase in B2 expression appears to occur in a rostrocaudal gradient, with 
more anteriorly-located ganglia (Figure 3B) expressing higher levels than those located 
more posteriorly (Figure 3D). SAl staining does not appear to fade in a complementary 
rostro-caudal manner, however (Figure 3A,C). Within "transitional" sympathetic ganglia 
at EI4.5, a complementary pattern of SAl and B2 expression is seen: regions of a given 
ganglion that are high in SAl (Figure 4A, arrow) are low in B2 (Figure 4B, arrow); 
conversely regions that are high in B2 are low in SAl (Figure 4A,B). However the 
overall domains of SAl and B2 expression in such ganglia appear roughly co-extensive . . 
By EI5.5-16.5, however, virtually all detectable SAl staining has disappeared, and the 
ganglia are unifonnly strongly B2+. Taken together, these data indicate that expression of 
B2 occurs subsequent to that of SA I during sympathoadrenal development, but that there 
is a period of transient overlap between these two markers. 
The SAl. B2 transition does not occur in the adrenal medulla 
Chromaffm cells derive from sympathoadrenal progenitors that continue migrating 
from the vicinity of the sympathetic ganglia to invade the adrenal gland primordium. This 
invasion begins between E13.5 - E14.5 (Bohn et aI., 1981; Teitelman et aI., 1982). 
These invading progenitors express SAl (not shown). In contrast to their counterparts in 
the sympathetic ganglia, however, they appear for the most part to maintain expression of 
this antigen after settling within the adrenal (Figure 4C). For example, at EI4.5, many 
cells expressing high levels of SAl can be observed deep within the adrenal gland (Figure 
4C,E; arrowhead), whereas in the adjacent sympathetic ganglion virtually no SAl staining 
is detectable (Fig. 4C, arrow). Conversely, the sympathetic ganglia exhibit a high level 
of B2 labeling (Fig. 4D, arrow), whereas only faint B2 staining is detected within the 
adrenal gland. In some sections, areas of intense B2 staining could be observed within 
the adrenal primordium (Fig. 4F, arrowhead.) However, these regions correspond to the 
future extra-adrenal ganglionic complex (EAGC) (Lempinen, 1964), a structure which 
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segregates from the adrenal gland proper, and eventually degenerates towards the end of 
gestation (Aloe and Levi-Montalcini, 1979). 
Cells classified as "chromaffm cells" by histochemical stains have been identified 
in the embryo in locations outside of the adrenal gland (Lempinen, 1964). Such "extra-
adrenal chromaffin cells" also appear to undergo the SAl .. B2 transition, like the cells in 
the sympathetic ganglia but unlike those within the adrenal gland (Figure 5). For 
example, clusters of cells expressing SA I can be observed in the para-aortic region (Fig. 
5A, arrows) at EI4.5. Patches of B2+ cells are present in some, but not all, of these 
SAl + para-aortic clusters (Fig. 5B, arrows). At higher magnification, the domains of B2 
and SAl staining appear to be partially overlapping (Fig. 5C,D; arrowhead), similar to the 
patterns in the transitional sympathetic ganglia (see above). 
The appearance of B2 correlates with a loss of competence for chromaffin 
differentiation 
The foregoing data indicated that neuroblasts in the sympathetic ganglia undergo a 
developmental change beginning on E13.5, in which they gradually extinguish expression 
of SAl and acquire expression of B2. By contrast, this change does not appear to occur 
for the majority of cells that migrate to the adrenal gland. In order to determine whether 
this change in antigenic phenotype reflects changes in the developmental properties of 
sympathoadrenal progenitors, we studied in culture the behavior of B2+ and B2- cell 
populations isolated from E14.5 adrenal glands. The adrenal gland was chosen for this 
experiment, because previous studies had indicated that, in addition to the majority B2-
chromaffin precursor population, a subset of B2+ cells is present (Anderson and Axel, 
1986; see also Fig. 4F); thus, both populations can be obtained from the same tissue. 
After isolating the B2+ cells, the B2- TH+ cells were separated from non-sympathoadrenal 
B2- cells using monoclonal antibody HNK-I (see Materials and Methods). This antibody 
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identifies sympathoadrenallineage cells in the adrenal gland, since all HNK-l + cells are 
also TII+ (Birren and Anderson, 1990). The majority (over 80%) of the B2-, HNK-l+ 
cells are also strongly SAl +, as determined by staining of fixed, permeabilized cells 
(n=300). By contrast, 81 % of freshly-isolated B2+ cells are SA 1-. This 
immunochemical fractionation thus separated the sympathoadrenal progenitor population 
from the E14.5 adrenal gland into predominantly B2+, SAl- and B2-, SAl + cells. 
B2+ cells appeared more advanced in their state of neuronal differentiation, and 
less able to develop into chromaffin cells, than the B2- SAl + cells. For example, after 24 
hrs in culture, 81 % of B2+ cell clusters were process-bearing, whereas only 47% of the 
B2- clusters bore neurites (Fig. 6A, No Add). In addition, the processes on B2+ cells 
tended to be longer, on average, than those on B2- cells (Anderson, 1988). By day 3, 
however, 76% of cell clusters in the B2- population had extended processes (data not 
shown), indicating that most if not all of these cells are neuronal precursors but that their 
differentiation lags behind that of the B2+ cells. 
The two cell populations also differed significantly in their ability to differentiate 
into chromaffin cells, as assessed by morphology and antigenic phenotype, in response to 
the synthetic glucocorticoid dexamethasone (dex). For example, after 24 hrs of culture in 
1 11M dex, the majority of B2- cell clusters exhibited a round, chromaffin morphology: 
only 13% were process-bearing (Fig. 6A, DEX, hatched bars). By contrast, under these 
same conditions, over 60% of the B2+ cells bore neurites (Fig. 6A, DEX, solid bars). 
Thus, dex inhibited process outgrowth 72% in the B2- population, but only 24% in the 
B2+ population. Chromaffin differentiation was also assessed by staining cells with 
antibodies to the chromaffin-specific marker enzyme phenylethanolamine-N-
methyltransferase (PNMT). After 3 days of culture in dex, over 80% of the B2- cells 
exhibited PNMT immunoreactivity, whereas less than 50% of the B2+ cells expressed 
PNMT (Fig. 6B). Taken together, these data indicate that the B2- population is less 
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advanced in neuronal differentiation, and has a greater capacity for chromaffin 
differentiation, than the B2+ population. 
Although the B2+ population on average is more advanced in neuronal 
differentiation than the B2' population, at the single cell level it is heterogeneous. 
Previous studies indicated that many B2+ cells continue to extend neurites and then die in 
glucocorticoid, but that a subset of cells can undergo chromaffin differentiation (Anderson 
and Axel, 1986). Serial observations of identified cells now indicate that these two 
subpopulations can be identified prospectively, by their different morphologies. We 
followed the fates of 72 individual B2+ cells in low-density cultures with dex, over a 3 
day period. 43 of these cells were initially process-bearing; of those, 86% died over the 
ensuing culture period (Fig. 7, arrow). The process-bearing cells that survived did not 
express detectable PNMT (not shown). On the other hand, of the 19 cells that survived 
and displayed a chromaffin phenotype, 84% derived from precursors initially lacking 
processes (Fig. 7, arrowhead). (The remaining 16% derived from cells initially bearing 
short processes.) These data indicate a strong correlation between the initial morphology 
of B2+ cells and their response to glucocorticoid: cells with short processes or a round 
morphology are likely to survive and differentiate into chromaffm cells, whereas process-
bearing cells are likely to continue to extend neurites, and then die. The response of 
sympathoadrenal precursors to glucocorticoid can therefore be predicted based upon a 
combination of cell morphology and antigenic phenotype. 
Expression of SAl and B2 in late gestational embryos 
The preceding observations revealed a good correlation between the position of 
sympathoadrenallineage cells in the embryo and their antigenic phenotype, around E14.5 
_ E15.5. Cells that migrate to the adrenal gland maintain expression of SAl and do not 
induce B2, whereas cells that migrate to the sympathetic ganglia extinguish expression of 
SAl and induce B2. At later stages of gestation, however (ca. E18.5), some violations of 
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this "rule" were observed. For example, scattered patches of B2+ cells can be observed 
deep within the adrenal medulla (Fig.8B). Conversely, patches of SAl+ cells can be 
observed outside of the adrenal microenvironment, in the EAGC (Fig. 8C). The EAGC 
also contains patches of brightly-stained B2+ cells (Fig. 8D, arrow). However, these 
patches exhibit a complementary, non-overlapping distribution relative to the patches of 
SAl + cells (Fig. 8D, arrowheads; compare to 8C). Thus, the mutual exclusivity of high 
B2 and high SAl labeling persists, despite the fact that some cells of each phenotype 
appear in the "inappropriate" location. 
The SAl + and B2+ patches can also be distinguished by their relative levels of TIf 
expression: SAl + patches are intensely stained with anti-TIf antibody (Fig. 8E,F), 
whereas B2+ patches are more weakly stained (not shown). B2+ patches conversely stain 
more intensely than SAl + patches with neuronal markers such as SCG 10 and NF68 (not 
shown.) This pattern of marker expression supports the idea that the B2+ patches contain 
cells with a more neuronal phenotype than the SA 1 + patches. 
DlSCllSSION 
Evidence for a bipotential sympathoadrenal progenitor in vivo 
Neural crest cells in the ventro-lateral migration pathway make a late 
developmental decision between the expression of an endocrine or a neuronal phenotype. 
In vitro studies (Anderson and Axel, 1986; Carnahan and Patterson, 1991b; Doupe et ai., 
1985b; Seidl and Unsicker, 1989b) have provided evidence that this decision is made by a 
progenitor cell whose choice of cell fate is determined, at least in part, by environmental 
factors. However, it has been difficult to verify this lineage relationship in vivo, because 
of the difficulties involved in tracing the fates of migratory cells in the mammalian 
embryo. In this study, we report the observation that at least some cells in embryonic 
sympathetic ganglia transiently co-express neural-specific and chromaffin-specific 
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markers. Cells that remain in the ganglion primordia lose expression of the chromaffin 
markers (SAI-5) and retain expression of the neuronal markers. Conversely, cells that 
migrate to the adrenal primordium lose expression of the neuronal markers (Anderson and 
Axel, 1986; Vogel and Weston, 1990) and retain expression of SAI-5. These data are 
consistent with the idea that the transiently dual-phenotype cells are bipotential progenitors 
of chromaffin cells and sympathetic neurons, which selectively repress expression of the 
neuronal or chromaffm markers according to their fmal choice of cell fate. 
An alternative explanation is that the disappearance of SAl immunoreactivity from 
the ganglion primordium at E14.5 is due to the death or emigration of SAl + cells. This 
seems unlikely, because initially the SAI+ cells are also TII+ and SCGlO+, and cells with 
a TII+, SCGlO+ phenotype remain in the ganglia even as SAl disappears. Moreover, we 
observe the concomitant appearance of a second marker, B2, in cells which are still 
weakly SA1+ (see below). Thus, the cells which are initially SAI+ appear to remain in 
the ganglion primordium and to change their antigenic phenotype, rather than to 
disappear. Furthermore, the isolation of SAl + cells from E13.5 sympathetic ganglia has 
revealed that 90% of these cells initially express neurofilament 140 kD, and that these 
cells have the capacity to develop either into chromaffin cells or sympathetic neurons, 
depending upon culture conditions (Carnahan and Patterson, 1991b). Taken together, 
these data indicate that the SA1+, SCGlO+ cells observed in embryonic sympathetic 
ganglia are likely to be precursors of sympathetic neurons in vivo. 
The phenomenon of transient marker co-expression followed by mutually-
exclusive segregation is reminiscent of several other cell lineages, wherein bi- or multi-
potential progenitors have been shown to give rise to closely-related but distinct cell 
types. In the immune system, for example, CD4+ and CD8+ peripheral T lymphocytes 
have been shown to derive from a progenitor that is initially double-positive for both of 
these cell-surface markers (Carbone et al., 1988; Fowlkes et aI., 1988). In the pituitary 
157 
gland, somatotrophs expressing growth hormone and lactotrophs expressing prolactin are 
thought to develop from precursors which transiently co-express both hormones 
(Roeffler et aI., 1985). Finally, in the endocrine pancreas, embryonic islet progenitor 
cells have been shown to initially co-express peptides, such as insulin and glucagon, 
which later segregate to different subpopulations of mature endocrine cells (Alpert et al., 
1988). 
This phenomenon could reflect the fact that the co-expressed genes are regulated, 
in part, by transcription factors which are common to all cells of a given lineage (Bodner 
et aI., 1988; Ingraham et aI., 1988). The later restriction of these markers to different 
subtypes of cells within the lineage could reflect the superposition of additional regulatory 
mechanisms, which fine-tune the pattern of gene expression. In the sympathoadrenal 
lineage, for example, the expression of neuronal markers such as SCG 10 can be up-
regulated by FGF and NGF (factors which promote neuronal differentiation), and down-
regulated by glucocorticoid (which promotes chromaffin differentiation) (Stein et aI., 
1988a). Conversely, chromaffin-abundant markers such as TH (Fig. 8E,F) are up-
regulated by glucocorticoid and down-regulated by NGF (Leonard et aI., 1987; Stein et 
al., 1988a). In this way, a repertoire of lineage-specific gene expression established in 
progenitor cells by a common transcriptional program may be fine-tuned by differences in 
local environment, generating further phenotypic diversification. 
Developing sympathetic neuroblasts undergo a switch in antigenic 
phenotype 
Our antibody markers revealed a relatively late developmental event in the 
differentiation of sympathetic ganglionic neuroblasts: as expression of the SA 1 antigen 
declines, the cells induce the expression of a surface antigen recognized by monoclonal 
antibody B2. At intermediate times, both SAl and B2 are expressed in the same ganglia, 
and the pattern of expression of these two markers appears co-extensive. Eventually, 
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SAl expression becomes undetectable and the cells in the ganglia unifonnly express high 
levels of B2. This pattern strongly suggests that the SA 1 .. B2 transition reflects a change 
in marker expression within a single population of cells, rather than the replacement of 
one population by another. This interpretation is reinforced by the complementary 
patterns of SAl and B2 staining seen within individual transitional ganglia: regions that 
are intensely SA1+ are weakly B2+, and vice-versa. Such inhomogeneous staining 
further suggests that the SAl" B2 switch occurs asynchronously for cells within a given 
ganglion. 
The SA 1" B2 transition provides an indication that the cells of the developing 
sympathetic ganglia are changing, in a way that is not otherwise detectable in vivo. In 
what way are the cells changing? The fact that expression of SA 1 precedes that of B2 
suggests that cells expressing the former antigen are at an earlier stage of neuronal 
differentiation than cells expressing the latter. Consistent with this idea, cells isolated by 
sorting with a cocktail of SA antibodies have a rounded morphology (Carnahan and 
Patterson, 1991b), whereas cells isolated by sorting with B2 tend to extend processes 
shortly after plating (Anderson, 1988). Moreover, most B2-, SAl + cells can be induced 
to differentiate into chromaffin cells at high frequency by glucocorticoid (see also 
Carnahan and Patterson, 1991b). By contrast, process-bearing B2+ cells are refractory to 
such an induction. As demonstrated previously (Anderson and Axel, 1986), a minority 
of B2+ cells remain responsive to glucocorticoid, but most of these cells initially exhibit a 
rounded morphology. The developmental heterogeneity within the adrenal B2+ 
population is consistent with the fact that 19% of freshly-isolated B2+ cells express SAL 
This could reflect the gradual nature of the SA 1 .. B2 transition, as suggested by the 
overlapping expression of SAl and B2 in sections of E14.5 sympathetic ganglia. 
Nevertheless, cells with a B2+, SA 1- antigenic phenotype and a process-bearing 
morphology have lost competence to respond to glucocorticoid and appear committed to 
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neuronal differentiation (Figure 9). The loss' of responsiveness to glucocorticoid may 
serve to "insulate" immature sympathetic neurons from the steep rise in circulating fetal 
corticosterone levels, which begins on E16.5 (Teitelman et aI., 1982). Loss-of-
competence is thought to be a feature of inductive processes in other embryonic systems 
(Grainger and Gurdon, 1989; Gurdon, 1987). 
Control of the SAl. B2 transition 
Cells that arrest migration in the sympathetic ganglia extinguish SAl and induce 
B2, whereas those that migrate into the adrenal primordium mostly fail to make this 
switch. Instead, chromaffin cells maintain expression of SAl into adulthood. This 
observation suggests that the SA I" B2 switch may be controlled by factors in the micro-
environments encountered by sympathoadrenal progenitors. SA antigen-positive 
progenitors from sympathetic ganglia reduce levels of SA I expression in the absence of 
dexamethasone, but maintain expression in the presence of dex (Carnahan and Patterson, 
199Ib). Moreover, chromaffin cells from neonatal rats lose SA staining in the presence 
of NGF and absence of glucocorticoid (Carnahan and Patterson, 199Ia). These in vitro 
results suggest that in vivo, progenitors within the adrenal primordium may be prevented 
from undergoing the SAl" B2 transition by the high local concentration of adrenal 
corticosteroids. The SA I .. B2 transition may also be promoted by factors which 
stimulate neuronal differentiation, such as FGF and NGF (Birren and Anderson, 1990; 
Carnahan and Patterson, 1991b; Stemple et al., 1988). 
The maintenance of SAl and failure to induce B2 are first apparent in the adrenal 
gland as early as E14.5 (Figure 4), suggesting that glucocorticoids and their receptor are 
functional at this early stage. mRNA encoding the glucocorticoid receptor has been 
detected in the adrenal gland as early as E15.5 (Anderson and Michelsohn, 1989). 
However, using a radioligand binding assay, Seidl and Unsicker (Seidl and Un sicker, 
1989b) have reported that glucocorticoid receptor is undetectable in adrenal medullary 
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precursors prior to EI6.5. The reason for this apparent discrepancy is not clear. 
Chromaffm precursors may contain a low level of receptor that is sufficient to mediate the 
inhibition of neuronal differentiation; alternatively the SAl" B2 transition may be 
suppressed in the early adrenal gland by factors other than steroid hormones. However, 
recent radioimmunoassay data indicate that the E 14.5 adrenal gland contains micromolar 
quantitites of glucocorticoid (A. Michelsohn and D.J. Anderson, in preparation.) 
Whatever the case, the SA I and B2 markers provide evidence that progenitors in the 
adrenal gland are phenotypically distinct from their ganglionic counterparts two days 
before they express PNMT, the only other marker previously able to distinguish 
chromaffin cells from sympathetic neurons (Bohn et al., 1981; Teitelman et al., 1982). 
The correlation between the antigenic phenotype of sympathoadrenal progenitors 
and their location in the embryo is not perfect: occasional clusters of B2+ cells can be 
found within the adrenal gland, and clusters of SA1+ cells are found outside of it,late in 
gestation. The B2+ clusters probably correspond to clusters of NPY+ cells observed by 
Henion and Landis (Henion and Landis, 1990). Similar clusters of cells with a neuronal 
phenotype have been found within the human fetal adrenal gland as well (Cooper et aI., 
1990). Our in vitro results provide a possible explanation for this phenomenon: these 
B2+ neuronal cells derive from precursors that have lost competence to respond to 
glucocorticoid, either prior to or shortly after migration to the adrenal primordium. The 
majority of these cells disappear by the first postnatal week, probably being eliminated by 
cell death (Henion and Landis, 1989). 
By the same token, at E18.5 some SA1+ cells can be found outside of the adrenal 
environment. Since the SAl" B2 switch appears to occur slowly and asynchronously, 
these cells may have failed to induce B2 by E16.5, and then have been prevented from 
doing so subsequently by the surge in fetal GC levels that occurs on EI6.5-17.5 
(Teitelman etal., 1982). The decision to retain the SAl antigen may, moreover, become 
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stabilized with further chromaffm development. Interestingly, the SA 1 + cells in the para-
aonic and extra-adrenal region are found in clusters, as are the B2+ cells. This suggests 
that once cells decide whether or not to make the SAl" B2 switch, they may reinforce 
their immediate neighbors to do likewise. Such a "community effect" has been 
demonstrated for the process of mesodermal induction in amphibia (Gurdon, 1988). 
------j.A~I:tcte:>l.lIn:aatrtively, such ciuSteIS could .eflect an aggregation (Henion and Landis, 1990) or 
clonal expansion of phenotypically similar cells. 
Using a series of antibody markers, we have defined a sequence of events during 
the development of the sympathoadrenal lineage in the rat embryo (Fig. 9). Bipotential 
sympathoadrenal progenitors initially co-express both chromaffin-specific and neuron-
specific markers, and then differentiate into neurons or endocrine cells depending upon 
the environment to which they migrate. Subsequently, additional changes in marker 
expression are detected: cells in the sympathetic ganglia switch from an SA 1 + to a B2+ 
phenotype, whereas this switch fails to occur for the majority of cells within the adrenal 
gland. Studies of isolated sympathoadrenal progenitors in vitro indicate that this switch 
correlates with a loss of competence to respond to glucocorticoids, an inducing signal for 
chromaffin differentiation. Taken together, these data indicate that the development of 
sympathetic neurons and adrenal chromaffin cells is controlled not only by environmental 
signals, but also by changes in the ability of cells to respond to such signals. Such 
changes illustrate one way in which the developmental capacities of initially multipotent 
cells can become restricted during differentiation. 
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FIGURE LEGENDS 
Figure 1. Initial expression of SAl occurs in developing sympathetic 
ganglia. 
Sections are through sympathetic ganglion primordia, at EI1.5 (A,B) the same 
section was doubly-labeled with SAl (FITC) and TIl (Rhodamine). (C,D) the same 
section was doubly-labeled with SAl and polyclonal anti-SCOlD. Arrows indicate 
individual doubly-labeled cells. (E,F) higher magnification view illustrating two process-
bearing cell bodies (arrows) doubly-labeled by SAl (F) and SCOlD (E). Arrowheads 
indicate the process from one cell, which is also doubly-labeled. Asterix in C and D 
indicates autofluorescent blood cells in the dorsal aorta. The specific staining patterns 
illustrated were not observed in controls lacking primary antibody. Scale bar = 33 ~. 
Figure 2. Co-expression of SAl with TH and SCGIO in E12.S 
sympathetic ganglia. 
A,B; C,D; and E,F represent doubly-labeled sections, respectively, stained with 
the antibodies indicated below the panels. In all cases the fluorochrome used for SAl 
was FITC. In (F), a faint patch of punctate B2 staining can be detected in a region 
containing SAI+ cells (arrow, E and F). However many ganglia showed no detectable 
staining with B2 at this stage of development. Asterisks indicate autofluorescent blood 
cells. Scale bar, 33 ~M. 
Figure 3. Initial appearance of B2 in sympathetic ganglia. 
A,B and C,D represent doubly-labeled sections through two different axial levels 
in the trunk region of an E13.5 embryo. The (A,B) pair lies more anterior (rostral) than 
the (C,D) pair. Panels A and C were photographed and printed using identical exposure 
times, as were Band D. Note that the B2 staining in (B) overlaps the region of the 
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sympathetic ganglion containing SA 1+ cells in (A). The B2 staining shows a 
characteristic punctate appearance. In the more caudally-located ganglion (0) the intensity 
of B2 staining is much weaker (compare with panel B). Compare the intensity of B2 
staining in (B) to that in Fig. 2F, one day earlier in development. Arrowheads (C,D) 
indicate SAl + cells which exhibit faint B2labeling. da, dorsal aorta. 
Figure 4. The SAl. B2 switch occurs in sympathetic ganglia, but not in 
the adrenal gland. 
(A,B) doubly-labeled pair from a section through an E14.5 sympathetic ganglion. 
Note that the levels of B2 staining by this stage are quite high (compare with exposure-
matched panels 2F and 4B,D). Note also that faint SAl staining in (A) can still be 
detected in the region of the ganglion which is strongly B2+. Arrow indicates a region 
which is still strongly SAI+ (A), but weak for B2 (B). (C,D) and (E,F) represent 
doubly-labeled pairs from two nearby sections through the adrenal gland at EI4.5. 
Arrowhead (C,E) indicates strongly SA 1+ chromaffin cells deep within the adrenal 
medullary region. Note that these same regions are negative or only faintly positive for 
B2 (O,F) . Arrow (C,D) indicates the nearby sympathetic ganglion; note the intense B2 
staining (0) and low SAl staining (C) . In (F), arrowhead indicates a patch of B2+ in the 
region that will become the extra-adrenal ganglionic complex (EAGC); note that this 
region also contains some brightly SAl + cells. Photographic exposure times are identical 
with those in Figs. 4 and 2 (E,F) for SAl and B2, respectively. Scale bar 63 ~M. 
Figure S. Expression of SAl and B2 by extra-adrenal chromaffin cells in 
the para-aortic region. 
(A,B) and (C,D) represent doubly-labeled pairs from two nearby sections through 
the lumbar region of an E14.5 embryo, posterior to the region containing the adrenal 
gland. Arrowheads in (A) indicate the sympathetic ganglia. da, dorsal aorta. Arrows in 
170 
(B) indicate patches of B2+ cells in the para-aortic region; some of these patches are also 
SAl + in (A). Note, however, a large SAl + patch in (A) (arrow, left) that is not labeled 
by B2 in (B). Similar patches in other sections are also labeled by anti-rn and anti-
SCG 10 (not shown). (C,D) is a higher magnification view of para-aortic cells. Note the 
large patch of SAl + cells that is not labeled by B2 (0, arrow), and the intense B2 staining 
that overlaps the SAl + region. Scale bar (A,B) 134 ~M. (C,D) are four times the 
magnification of (A,B). 
Figure 6. B2+cells show a reduced capacity for chromaffin differentiation 
compared to B2- cells. 
B2+ and B2- (HNK-l +) cells were isolated from E14.5 adrenal glands (see 
Materials and Methods) and cultured with or without I ~ dexamethasone ("DEX"). (A) 
After 24 hrs in culture, the population was scored for the percentage of cell clusters 
bearing processes (see Materials and Methods). Only the rn+ cell population was 
counted; contaminating flat cells were not included. Note that in DEX, only 13% of B2-
clusters had processes, whereas 61 % of B2+ clusters had processes. The method of 
analysis probably underestimates the difference between B2+ and B2- cells (see Materials 
and Methods). (B) After 3 days in culture, the population was fixed and stained with an 
anti-PNMT antibody, and the percentage of surviving cells expressing PNMT 
determined.. Time course experiments indicate that most cells that can express PNMT 
have done so by 3 days of culture in DEX (A. Michelsohn and D. Anderson, 
unpublished.) Data are the mean ±SEM of 4-6 determinations from two independent 
experiments. 
Figure 7. B2+ cells bearing processes fail to respond to glucocorticoid 
Individual B2+ cells were identified 24 hrs.after plating in 1 ~M DEX and 
photographed every 24 hrs for the next two days. Numbers indicate hours of culture. 
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Arrow indicates an example of a pair of process-bearing cells that failed to respond to 
DEX. Note at 48 hrs the phase-bright pycnotic figures near the remaining two phase-gray 
living cells, suggestive of cell division followed by cell death. At 72 hrs only a single 
pycnotic figure is visible (arrow). Arrowhead indicates an example of a non-process-
bearing cell (or cell cluster) that survived and displayed a rounded chromaffin 
morphology. Antibody staining indicated that cells of this phenotype were PNM'f+ (not 
shown). Note that process-bearing cells were also observed to die in cultures lacking dex 
(not shown), indicating that the death of these cells is not caused by glucocorticoid. The 
extent of cell death is greater in the low-density cultures used in these single cell-tracking 
experiments, than in the mass cultures used in population experiments; therefore the 
results of the two types of experiments are not quantitatively comparable. 
Figure 8. Patches of B2+ and SAl+ cells that violate the positional 
"rule." 
Shown are sections from an E18.5 embryo. (A,B) doubly-labeled pair through 
the adrenal gland. Note the large patch ofB2+ cells (B), which is SAl- (A). In (A), the 
SA I staining is obscured by a high level of autofluorescence, but is clearly visible as 
punctate labeling at the margin of the B2+ zone. (C,D) doubly-labeled pair through the 
extra-adrenal ganglionic region. Note the intensely-stained patch of B2+ cells (arrow, D) 
which is SA 1- (C). Arrowheads in (D) indicate two less intensely-stained B2+ patches, 
which flank a SAl + patch (C). (E,F) doubly-labeled pair through an EAGC, illustrating 
adjacent patches of SAI+, THhi cells, and SAl-, rnlo cells. The SAl- patches would be 
B2+ (as, for example, in C and D, arrowheads.) Scale bar, 62 1lM. 
Figure 9. Schematic diagram illustrating sequence of antigenic changes in 
the sympathoadrenal lineage. 
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The earliest bipotential progenitors are SAI+ and B2-. They co-express neuron-
specific markers such as SCG 10 and chromaffin-specific markers such as SAI-5, as 
illustrated by the double cross-hatching. In this study, progenitor cells were isolated from 
E14.5 adrenal glands using monoclonal antibody HNK-I in combination with B2-
mediated complement lysis. Most but not all of these cells are also SA I +; those cells 
lacking SA I may have initiated neuronal differentiation. In the absence of 
glucocorticoids, these progenitors differentiate along the neuronal pathway, a process 
promoted by FGF and perhaps other, as yet unidentified factors. Cells that are B2+ and 
SA 1- and which bear processes have lost competence to respond to glucocorticoid 
("committed neuroblast"). For clarity, intermediate stages of development between the 
bipotential progenitor and committed neuroblast are omitted. 
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